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Abstract
Diabetes mellitus (DM) is a major and worsening global health problem. Type 2
diabetes mellitus (T2DM) accounts for more than 90% of DM and the global epidemic of
obesity largely explains the dramatic increase in the incidence and prevalence of T2DM
over the past 20 years. Cardiovascular complications are the major cause of morbidity and
mortality in diabetic patients. The electrocardiogram (ECG) of diabetic and obese patients
is frequently disturbed. The aim of this project was to characterize and clarify the
molecular basis of electro-mechanical dysfunction in the hearts of type 2 diabetic and type
2 diabetic/obese rats. Experiments were performed in Zucker diabetic fatty (ZDF), Zucker
fatty (ZF) and Zucker lean (ZL) rats. In vivo biotelemetry experiments were performed to
establish how the ECG was altered by diabetes and diabesity. Experiments were also
carried out in isolated heart to further investigate how diabetes and diabesity affects the
electrical conduction system of the heart. Cell imaging was employed to assess ventricular
myocyte shortening. Fluorescence photometry and whole-cell patch-clamp techniques
were used to assess the effects of diabetes and diabesity on ion channel currents. Molecular
biology and electron microscopy techniques were employed to assess proteins and
structures associated with cardiac muscle contraction. Heart rate (HR) was reduced by
ageing and by diabesity in the absence of changes in physical activity and body
temperature. Reductions in heart rate variability linked with altered sympathovagal drive
may partly underlie disturbed HR in the ZDF rat even in the absence of autonomic nervous
system control in the isolated perfused heart. Amplitude of shortening is generally well
preserved in ZDF myocytes. There was evidence of altered time course of the Ca2+
transient and shortening in ventricular myocytes from ZDF rat. Molecular and structural
defects in the ZF and ZDF rat heart were observed. The results suggest that sarcoplasmic
reticulum (SR) Ca2+ handling as well as energy utilization are compromised in ZDF and
ZF myocytes. Myocyte contraction and relaxation may also be affected in the ZDF and ZF
rat due to protein and ventricular structural defects. Isoprenaline was less effective at
generating an increase in the AMP of shortening in ZDF and ZF compared to ZL myocytes
and defects in Ca2+ signaling, and in particular SR Ca2+ transport, might partly underlie
these abnormalities.
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)Title and Abstract (in Arabic
األساس الجزيئي العتالل عضلة القلب السكري

الملخص
مرض السكري ( )DMهو مشكلة صحية عالمية رئيسية وتزداد سو ًءا .يمثل داء السكري من النوع 2
( )T2DMأكثر من  ٪90من  ، DMويفسر وباء السمنة العالمي إلى حد كبير الزيادة الهائلة في حدوث وانتشار
 T2DMعلى مدار العشرين عا ًما الماضية .مضاعفات القلب واألوعية الدموية هي السبب الرئيسي للمراضة والوفيات
كثيرا ما يُضطرب مخطط كهربية القلب ( )ECGلمرضى السكري والسمنة .كان الهدف من هذا
في مرضى السكريً .
المشروع هو توصيف وتوضيح األساس الجزيئي للخلل الوظيفي الكهروميكانيكي في قلوب مرضى السكري من النوع
 2والسكري من النوع  / 2السمنة .أجريت التجارب على جرذان زوكر المصابة بداء السكري ( )ZDFوفئران زوكر
الدهنية ( )ZFوفئران زوكر الخالية من الدهون ( .)ZLأجريت تجارب القياس الحيوي في الجسم الحي لتحديد كيفية
تغيير تخطيط القلب بسبب مرض السكري والسمنة السكرية .وأجريت التجارب أيضًا في القلب المنعزل لمزيد من
التحقيق في كيفية تأثير مرض السكري و والسمنة السكرية على نظام التوصيل الكهربائي للقلب .تم استخدام التصوير
الخلوي لتقييم تقصير الخاليا العضلية البطينية .تم استخدام تقنيات قياس الضوء الفلوري ومشبك الخلية الكاملة لتقييم
آثار مرض السكري و والسمنة السكرية على القنوات األيونية .تم استخدام تقنيات البيولوجيا الجزيئية والمجهر
اإللكتروني لتقييم البروتينات والهياكل المرتبطة بانقباض عضلة القلب .انخفض معدل ضربات القلب ( )HRمع التقدم
في السن والسكري مع عدم وجود تغيرات في النشاط البدني ودرجة حرارة الجسم .قد تكمن التخفيضات في تقلب معدل
ضربات القلب المرتبطة بمحرك الودي المهبلي المتغير جزئيًا وراء اضطراب الموارد البشرية في الجرذ  ZDFحتى
في غياب التحكم في الجهاز العصبي الالإرادي في القلب المعزول المروي .يتم حفظ سعة السمن جيدًا بشكل عام في
الخاليا العضلية  .ZDFكان هناك دليل على المسار الزمني المتغير لـ Ca2+عابر وتقصير في الخاليا العضلية البطينية
من الفئران  .ZDFلوحظت عيوب جزيئية وتركيبية في قلب الجرذان  ZFو  .ZDFتشير النتائج إلى أن معالجة الشبكة
الساركوبالزمية ) Ca2+(SRوكذلك استخدام الطاقة تتعرض للخطر في الخاليا العضلية  ZDFو  .ZFقد يتأثر تقلص
الخاليا العضلية واسترخائها أيضًا في الجرذان  ZDFو  ZFبسبب عيوب البروتين والعيوب البطينية الهيكلية .كان
 Isoprenalineأقل فعالية في توليد زيادة في  AMPللتقصير في  ZDFو  ZFمقارنة بالخاليا العضلية  ZLوالعيوب
في إشارات  ، Ca2+وخاصة نقل  ، Ca2+ SRقد تكمن جزئيا ً في هذه التشوهات.
مفاهيم البحث الرئيسية :القلب ،السكري ،السمنة ،اعتالل عضلة القلب السكري ،جرذ زوكر الدهني السكري ،جرذ
زوكر الدهني ،الجرذ زوكر العجاف.
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Chapter 1: Introduction
1.1 Heart anatomy and physiology
The heart continuously beats to pump blood and circulate it around our body. The
heart is a fibromuscular hollow organ that is shaped like an irregular cone. It is encased in
the fibrous pericardium sac, occupying the center mediastinum. 1/3 of the heart rests to
the right of the sagittal (or median) plane of the body and 2/3 to the left of this plane. It is
resting in the center mediastinum, in the middle of the left and right pleural sacs, its long
axis rests diagonally beside a line passing from the left mid-clavicular line anteriorly, to
the right mid-scapular line posteriorly (Mahadevan, 2012). Looking into the pericardium
sac itself, it is further composed of different layers, mainly three layers of muscles, the
epicardium or the external layer, the middle layer or myocardium and the innermost layer
or endocardium (Lockhart et al., 2014). The myocardium is responsible for ventricular
contraction and consists of strong muscular tissue. The outmost layer, termed the “fibrous
pericardium”, which is a fibrous, tough, dense and rigid layer. The fibrous pericardium is
fused inferiorly with the main tendinous part of the diaphragm, whereas anteriorly it is
affixed to the rear exterior of the sternum by bands of connective tissue termed
“sternopericardial ligaments” (Figure 1). Inside the fibrous pericardium is the “serous
pericardium”, which is comprised of two layers. The outer layer termed the “parietal layer”
which is positioned to the inner surface of the fibrous pericardium. This layer is displayed
over the bases of the great vessels to become permanent with the inner visceral layer
(commonly named epicardium), which wraps the surface of the heart, and is securely
connected to it. Amongst the visceral and parietal layers of the serous pericardium is the
“pericardial cavity”, which comprises a thin film of fluid which permits the pounding heart
to slide frictionless within the pericardium. The pericardial cavity also has two important
inlets: the “transverse sinus” and the “oblique sinus”. The transverse sinus sits at the rear
of the roots of the aorta and pulmonary trunk, where it is restricted posteriorly by the atrial
chambers. While the oblique sinus, positioned at the rear of the left atrium, is constrained
right-handedly by the right pulmonary veins and inferior vena cava, and left-handedly with
the left pulmonary veins. The fibrous pericardium merges through the walls of the great
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vessels (inferior and superior vena cava, pulmonary trunk, four pulmonary veins, and the
ascending aorta) where these vessels pierce the fibrous pericardium (Mahadevan, 2012).

Figure 1: The heart and pericardium frontal view. Adapted from (Mahadevan, 2012).
1.2 Heart chambers and valves
The heart has a ‘fibrous skeleton’ composed of dense collagen that acts as an anchor
for the cusps of the heart valves and for the myocardium of the cardiac chambers. The
skeleton is a combination of four fibrous rings (equivalent to the left and right
atrioventricular cavities, as well as the cavities of the pulmonary trunk and aorta) and the
attached parts of the inter-atrial and inter-ventricular septal wall that separates these
chambers (Figure 2). Collectively, the heart has four chambers: The right and left atrium
as well as the right and left ventricle. It also has four cardiac valves that rest behind the
body of the sternum alongside a nearly vertical line. They are the aortic valve, pulmonary
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valve, mitral valve, and tricuspid valve. Normal heart sounds or beats are the outcome of
rapid collocation of valve cusps at the time of valve closure and are simply recorded by
auscultation. The right atrium is largely composed of a smooth interior. Part of the anterior
wall and the atrial appendage have trabeculated interiors. There is a vertical ridge on the
inner aspect of the anterior wall termed the “crista terminalis”. Another parallel groove on
the exterior wall is termed the “sulcus terminalis” while the posterior wall of the right
atrium is the “interatrial septum”. The openings of the inferior and superior vena cava are
on the floor and roof, respectively. Towards the left of the inferior vena cava opening is
the opening of the coronary sinus, which sends the majority of the venous return to the
right atrium. To the left of the opening of the coronary sinus is the tricuspid opening
(shielded by the tricuspid valve), heading to the right ventricle. Directly over the opening
of the coronary sinus, in the adjoining portion of the interatrial septum, is the
atrioventricular node (AVN). The intersection of the sulcus terminalis and superior vena
cava indicates the position of the sinoatrial node (SAN). The left atrium is composed of
smooth walls apart from within the left atrial appendage. Penetrating the posterior wall of
the left atrium, on either side, are the subsequent lower and upper pulmonary veins. The
inferior part of the left atrium holds the mitral opening (protected by the mitral valve)
leading towards the left ventricle (Dal-Bianco & Levine, 2013; Mahadevan, 2012; Mori et
al., 2016).

Figure 2: Heart Anatomy. Adapted from (Marks, 2019).
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1.3 Cardiac myocytes
These striated muscle cells are the essential components of heart muscle, and their
primary role is to produce mechanical tension (Figure 3). Myocytes are enclosed by a lipid
membrane called the “sarcolemma”, which separates the cell exterior from the interior
compartments. Myocytes may have one or more nuclei which are usually located at the
center. Moreover, they contain mitochondria, myofibrils, the sarcoplasmic reticulum (SR),
the sarcomeres and the cytoskeleton, that provides anchoring for the different organelles.
The intracellular space is filled with the sarcoplasm, an aqueous solution containing lipids,
various ion species, carbohydrates and proteins. The plasma membrane (sarcolemma) of
one cardiac cell is joined tightly with its neighbor by intercalated disks, which contain gap
junctions that permit the rapid passage of electrical impulses in the form of ions from one
cell to the next. The intercalated disks allow cells of the myocardium to work together in
a coordinated manner as a functional syncytium. Moreover, the sarcolemma forms
membrane-lined channels, which penetrate the cell and develop into transverse (T)
tubules. The T-tubules permit extracellular fluid and ions to disperse close to intracellular
structures. T-tubules, which contain a high density of voltage-gated L-type calcium
channels, are located in close proximity to the SR, the primary internal Ca2+ store.
Sarcomeres form myofibrils, which are responsible for contraction upon Ca2+ release. The
Golgi apparatus serves as the “loading dock” and the microtubules serve as “highways”,
to deliver ion channels to certain subdomains on the plasma membrane. Mitochondria
provide the energy needed for the contraction of cardiomyocytes. Intercalated discs found
at the ends of each ventricular cardiomyocyte facilitate the cell-to-cell propagation of
action potentials (APs) (Hong & Shaw, 2017).
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Figure 3: Cardiac Myocyte. Adapted from (Hong & Shaw, 2017).
1.4 Sarcomeres
The basic components of the sarcomeres are the myofilaments and, they are the
fibers that generate contraction. They are composed of titin filaments and repeating units
of thin and thick filaments (Figure 4). Titin, an intracellular anchor protein, works as a
spring both at rest and during contraction. Thin filaments are comprised of actin and the
regulatory proteins tropomyosin (Tm) and troponin (Tn), while thick filaments are
comprised of myosin and accessory proteins. Rod domains of myosin heavy chains consist
of the backbone, and globular heads called cross-bridges protrude outward from that
backbone. Light chain accessory proteins bound to the myosin globular heads deliver
structural reinforcement of cross-bridges but in some contractile systems, particularly
smooth muscles and non-muscle systems, provide a regulatory function. The interaction
of myosin cross bridges with actin generates contractile force (Golob et al., 2014).
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Figure 4: Sarcomere structure. Adapted from (Golob et al., 2014).
1.5 Electrical system of the heart
The heart is a four chambered pump that functions to distribute blood to all the
organs in the body. It is comprised of left and right atria and left and right ventricles. The
right side of the heart pumps blood through the pulmonary circulation and the left side of
the heart pumps blood through the systemic circulation. The contraction of atria and then
the ventricles proceed in an orderly manner and is controlled by a specialized electrical
conduction system comprising the SAN, the AVN, left and right bundle branches and the
Purkinje fibers (Figure 5).
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Figure 5: Diagram showing pacemaker site and conduction pathways within the heart.
Sinoatrial node (SAN), atrioventricular node (AVN), left bundle branch (LBB), right
bundle branch (RBB). Adapted from (Martín et al., 2015).
Electrical activity of the heart is initiated by specialized cells in the SAN which is
located in the upper part of the wall of the right atrium. SAN cells have the ability to
spontaneously generate APs (Crawford et al., 2009).
APs generated by SAN cells are rapidly conducted across the atria and then, after a
brief delay in the AVN, are conducted rapidly across the ventricles. APs in SAN cells, as
in other conducting and muscle cells of the heart, are caused by changes of ion
conductance in specialized ion channels (Martín et al., 2015). Typical SAN and atrial
muscle APs are shown in Figure 6.

34

Figure 6: Diagram showing the action potentials from the SAN and atrial muscle of rabbit
heart. Adapted from (Boyett, 2009).
1.6 Sinoatrial node action potential
SAN cells are able to generate spontaneous APs which allow them to set the normal
electrical rhythm and rate in a healthy heart (Boyett, 2009; Kashou & Kashou, 2018). SAN
cells have unstable resting membrane potentials (RMPs) (Phase 4). During phase 4 of the
SAN AP hyperpolarization-activated cyclic-nucleotide (HCN) channels or “funny current
(If)” channels open and there is an inward current carried by Na+ and K+. Opening of these
channels leads to a small depolarization of the SAN membrane potential. L-type and Ttype Ca2+ currents also contribute to phase 4 of the SAN AP (Figure 7). When the
membrane potential reaches threshold, an AP is generated in each myocyte of the heart.
L-type Ca2+ current (ICaL) is largely responsible for phase 0. Closure of L-type Ca2+
channels and opening of K+ channels, including the delayed rectifier K+ channels (IKr) and
(IKs) repolarize the cell giving rise to phase 3 of the AP (Bartos et al., 2015; Boyett, 2009).
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Figure 7: Diagram showing SAN depolarization. Adapted from (Czick et al., 2016).
1.7 Cardiac muscle action potential
The heart muscle AP contains five phases. Recording from a typical body surface
electrocardiogram (ECG) and a ventricular AP are shown in Figure 8. APs generated in
the SAN spread rapidly through the atria and stimulate contraction of the atria muscle. The
P wave of the ECG represents depolarization of the atria. Electrical activity spreads from
the atria to the AVN, where there is a short delay, before electrical activity quickly spreads
through the ventricular myocardium. The QRS wave of the ECG represents ventricular
depolarization and the T wave represents ventricular repolarization (Boyett, 2009; Kashou
& Kashou, 2018).
The first phase of the AP (phase 0) is caused by the opening of fast Na+ channels
with high voltage sensitivity, and rapid regenerative influx of Na+, which depolarizes the
membrane from the RMP (-90 mV) to around +30 mV. The Na+ channels are rapidly
inactivated and a transitory opening of the K+ channels causes a transitory early
repolarization (phase 1). The plateau phase mainly results from activation of voltage-gated
L-type Ca2+ channels (phase 2). The closure of the Ca2+ L-type channels and the opening
of the K+ voltage-gated channels results in cell repolarization (phase 3). Finally, the
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membrane potential returns to resting levels (phase 4) (Pinnell et al., 2007; Shih, 1994)
(Figure 8).
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Figure 8: Diagrams showing action potentials of cardiac Myocyte. (A) Surface
electrocardiogram and (B) ventricular action potential. Adapted from (George, 2013).
Once the APs have spread across the atria, they are conducted to the AVN. There
is a short delay in AVN conduction before the APs are rapidly conducted across the
ventricular myocardium. The AVN can be seen as a secondary heart pacemaker. The AVN
is a subendocardial structure located in the lower posterior right atrium, in an anatomical
region on the posterior border of the coronary sinus ostium, superiorly to the tendon of
Todaro and anteriorly to the septal tricuspid valve annulus. This anatomic region is also
commonly referred to as the “triangle of Koch”. The AVN beats at a lower rate than the
SAN, around 40-60 beats per minute. The delay in signal transmission in the AVN allows
the atria to complete contraction before the ventricle chambers contract. After passing
through the AVN the wave of depolarization quickly spreads to the his bundle branches,
the Purkinje fibers , and through the myocardium (Bartos et al., 2015; Boyett, 2009;
Hafeez & Grossman, 2018).
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1.8 Excitation-contraction coupling
The excitation contraction coupling (ECC) process couples the electrical activity of
the heart with mechanical contraction of the heart muscle (Figure 9). The generation of
APs leads to the opening of L-type Ca2+ channels during phase 2 of the AP and a small
influx of Ca2+. This small influx of Ca2+ binds to ryanodine receptors (RYR) in the SR and
prompts a large release of Ca2+ from the SR. This process is so called “Ca2+-induced Ca2+
release”. There follows a rise in cytoplasmic Ca2+ referred to as the Ca2+ transient. The
Ca2+ binds to Troponin C (TnC) which in turn causes tropomyosin (Tm) to reveal the
active binding site of the myosin myofilaments triggering a shift and binding of myosin to
actin proteins producing muscle contraction. After the cycle ends, the muscles relax and
Ca2+ is released from the myofilaments. The Ca2+ that was released from SR is returned to
the SR by the Ca2+-ATPase pump (SERCA) and the Ca2+ that entered the cell through the
L-type Ca2+ channels is ejected, primarily by the Na+/Ca2+ exchanger (NCX), but to a
lesser extent by the cell membrane Ca2+ ATPase (Bers & Despa, 2013; Landstrom et al.,
2017; Martín et al., 2015; Pfeiffer et al., 2014; Silverthorn et al., 2007).

Figure 9: Illustration depicting the excitation-contraction coupling process in the heart.
Adapted from (Silverthorn et al., 2007).
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1.9 Voltage-gated channels of the heart
Since the spread of APs depends on the voltage-gated channel, it is helpful to
discuss them in more detail. Voltage-gated ion channels are important transmembrane
proteins that help control physiological processes such as cardiac muscle cell contraction
and relaxation. In the heart, voltage-gated ion channels include Ca2+, Na+, K+ and Clchannels. The voltage-gated Na+ channels and the voltage-gated Ca2+ channels are usually
present in the cell membranes of most excitable cells (Catterall, 2000, 2005; Hille, 1978;
McGivern & Worley, 2007).
Voltage-gated Na+ channels are composed of a single α subunit and one or two β
subunits as shown in Figure 10. The α subunit consists of four homologous domain regions
(I-IV) of six transmembrane spanning segments (S1-S6) and a pore forming loop. The
segment S4 is the voltage sensor and a channel gate modulator. The pores that allow Na+
ions to pass also have a fatty acyl chain that allows small hydrophobic inhibitors to pass.
The pore forming Na+ channel α subunit, is an “Asp-Glu-Lys-Ala” (DEKA) motif which
controls Na+ selectivity (Catterall, 2000, 2005; Hille, 1978; McGivern & Worley, 2007).
The voltage-gated Ca2+ channels [Cav1-3] are proteins that allow the passage of
Ca2+ ions. These channels are hetero-oligomeric complexes of different subunits of α, β, γ
and δ that assemble into 5 units, the pore forming α subunit (α1) and at minimum two
accessory subunits α2δ and β, hence the term “hetero-oligomeric”. So far 10 cloned αsubunits have been identified and make up three main families: 1) The most abundant
[Cav1.x] L-type Ca2+ Dihydropyridine-sensitive (high voltage long or slow inactivation),
2) [Cav2.1] P/Q-type Ca2+ current Dihydropyridine-insensitive (High voltage-activated,
moderate voltage-dependent inactivation), [Cav2.2] N-type Ca2+ current (High voltageactivated, moderate voltage-dependent inactivation), [Cav2.3] R-type Ca2+ current
(moderate voltage-activated, fast voltage-dependent inactivation) and 3) [Cav3.x] T-type
Ca2+ (Low voltage-activated, moderate voltage-dependent inactivation). The T-type and
L-type Ca2+ channels variously contribute to pacemaker cell APs. Just like the voltagegated Na+ channels, each α-subunit is composed of four homologous regions (I-IV) of six
transmembrane domains (S1-S6) where the S4 is responsible for the gating function. The
α2δ and β subunits augment expression as well as regulate the voltage dependence and
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gating kinetics of the α1 subunit. The Ca2+ channel α subunit four glutamate residues, “the
EEEE motif”, are responsible for Ca2+ selectivity (S. Alexander et al., 2013; Catterall,
2000; H. Huang et al., 2017).
Potassium (K+) channels can be divided into three major groups differing in the
channel structure formed by the pores. The first group of voltage-dependent K+ currents
(Kv) originated from six different families of channel proteins built upon Drosophila
melanogaster nomenclature. The K+ currents involved in this group consist of the Ca2+
activated K+ channels, transient outward K+ channels and KCNQ channels. Each form of
tetrameric structure consists of six transmembrane segments S1-S6 subunits and
cytoplasmic C- and N-termini. The segments S1-S4 shift in response to voltage changes
and function as channel voltage sensors. The second group of K+ channels comprises of
two transmembrane segments S1–S2, conducting three inward K+ currents which are:
ATP-sensitive K+ (KATP) channels, the inward-rectifying K+ (Kir) channels and G
protein-coupled inwardly-rectifying K+ (GIRK) channels (Snyders, 1999). The S1 and S2
segments are linked by a pore-forming P-loop. The third group of K+ channels are the most
abundant with more than 50 members. Each have a two-pore P1 and P2 structure with four
transmembrane segments S1–S4. The glycine-tyrosine-glycine (GYG) motif is the key
sequence for K+ selectivity in the pore region. A gene called “KCNH2” codes for the
Kv11.1 channel, recognized as the human Ether-à-go-go Related Gene (hERG), which
carries the inward delayed rectiﬁer K+ current (IKr), a vital element of repolarization during
the cardiac AP. Obstruction of IKr impedes cardiac repolarization, extending action
potential duration (APD) and the QT interval of the ECG, and hypothetically increases the
risk for the development of the cardiac arrhythmia such as: Torsades de Pointes (TdP).
The molecular structures of the different cation channels are shown in Figure 10 (Chen et
al., 2015; Gutman, 2005; H. Huang et al., 2017; Snyders, 1999).
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Figure 10: Structure of voltage-gated Na+, Ca2+ and K+ channels. Adapted from (H.
Huang et al., 2017).
1.10 Molecular biology
The human body consists of cells which are the basic functional units of living
organisms. An individual cell can carry out all the processes of life (Figure 11). All living
organisms store genetic information within the cell nucleus as nucleic acids which are
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) and transmit them to future
generations of cells. Through the use of a common genetic code, the cell can transfer
genetic information from DNA to RNA to protein, it can make use of proteins and some
RNAs to catalyze chemical reactions. It can also synthesize proteins in ribosomes, derive
energy by breaking down simple sugars and lipids, use adenosine triphosphate (ATP) as
their energy currency, and separate their cytoplasm from the external environment by
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means of phospholipid membranes containing pumps, carriers, and channels (Silverthorn
et al., 2007; Thomas et al., 2017).

Figure 11: The Eukaryotic cell with internal components. Adapted from (Thomas et al.,
2017).
Nucleic acids play an important role in many cell processes, including storage and
transmission of genetic information and energy. A single nucleotide is a three-part
molecule composed of one or more groups of phosphates, a five-carbon sugar and a
carbon-nucleotide structure called a nitrogen base. Many millions of nucleotides are joined
together to form DNA usually in the form of a double-stranded double helix. Each
nucleotide contains one of the two possible sugars of either the 5-carbon sugar ribose or
deoxyribose (ribose without oxygen). There are two types of nitrogen bases, purines and
pyrimidines. The purines have a double ring structure while the pyrimidines have a single
ring. There are two purines, adenine and guanine, and three pyrimidines, cytosine,
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thymine, and uracil. The smallest nucleotides consist of the energy-transferring
compounds ATP and adenosine diphosphate (ADP) (Silverthorn et al., 2007) (Figure 12).

Figure 12: Nucleotides and nucleic acids. Adapted from (Silverthorn et al., 2007).
In order to be transmitted from one generation to the next, DNA must be replicated
by special proteins (i.e. DNA polymerase) that unzip the DNA double helix and build new
DNA by pairing new nucleotide molecules to the two existing DNA strands that results in
two double-stranded DNA molecules (Silverthorn et al., 2007) (Figure 13).
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Figure 13: DNA replication. Adapted from (Silverthorn et al., 2007).
The general flow of information from DNA to RNA to protein is termed the “central
dogma” of molecular biology (Figure 14). The copying process in which a DNA serves as
a model for RNA synthesis is called transcription. In summary there are three major types
of RNA that participate in the process of protein synthesis which are ribosomal ribonucleic
acid (rRNA), transfer ribonucleic acid (tRNA), and messenger ribonucleic acid (mRNA).
Transcription produces mRNAs that are translated into sequences of amino acids such as
proteins or polypeptide chains. The main function of mRNA is to transmit genetic
information from nuclear DNA to cytosols where it is used as a template for protein
synthesis while rRNA is a component of the ribosomes. On the other hand tRNA serves
as an “adaptor” molecule that carries a specific amino acid to the site of protein synthesis
(Harvey & Ferrier, 2011).
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Figure 14: Central dogma of molecular biology. Adapted from (Harvey & Ferrier, 2011).

1.11 Statement of the problem
Diabetes mellitus (DM) is a key and worsening global and international health
problem, presently affecting more than 570 million people and reducing their quality of
life. Type 2 diabetes mellitus (T2DM) accounts for more than 90% of DM and the global
epidemic of obesity, which largely explains the dramatic increase in the incidence and
prevalence of T2DM in the past 20 years. Obesity is a major risk factor for DM which in
turn is a key source of mortality and morbidity in diabetic individuals. The molecular and
electro-mechanical function of the heart is often compromised in diabetic patients. The
aim of this dissertation is to clarify the molecular basis of electro-mechanical dysfunction
in obesity and diabesity. The electro-mechanical function of hearts will be explored in
Zucker diabetic fatty (ZDF) and Zucker fatty (ZF) rats and compared to Zucker Lean (ZL)
controls. The following sections will discuss diabetes and obesity in more detail.
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1.12 Diabetes: Epidemiology and pathophysiology
DM is a major metabolic disorder in which patients have elevated blood glucose or
hyperglycemia (Hg). DM is a major global health crisis. Statistics from the International
Diabetes Federation (IDF) in 2021 (International Diabetes Federation, 2021), reveal that
573 million adults between the ages of (20-79 years) worldwide had DM. The number of
diabetic patients is expected to reach 643 million by the year 2030 and around 783 million
by the year 2045. In 2021, there were an estimated 73 million people with diabetes in the
Middle East and Northern Africa (MENA) region. Diabetes is divided into various types.
Type 1 diabetes mellitus (T1DM) is characterized by almost total destruction of pancreatic
cells, which usually leads to an absolute lack of insulin. T2DM is the most common form
of diabetes and accounts for more than 90 percent of DM. In T2DM, in addition to
progressive β-cell failure, there is also evidence of insulin resistance (IR) and insulin
deficiency. The third type of DM affects pregnant women, known as gestational diabetes
(GD), which is characterized by IR and insulin deficiency. Other forms of diabetes include
types related to genetic defects of β-cell function, genetic defects in insulin action,
endocrinopathies, drug or chemical-induced and diseases of the exocrine pancreas
(Mayfield, 1998). When the disease is diagnosed late or untreated, it can cause a number
of long-term complications, including DCM, which causes the patient’s quality of life to
be reduced. Cardiovascular diseases (CVDs) are the main cause of mortality and morbidity
in diabetic patients (Low Wang et al., 2016). In young people with T1DM ages between
(8-43 years), around 5 people out of 1,000 die from CVDs on a yearly basis, whereas
among middle-aged people with T2DM living in high and middle income countries, up to
27 people out of 1,000 die from CVDs each year; a third of them die from stroke, and a
quarter die from coronary artery disease (CAD) (International Diabetes Federation., 2017).
Electro-mechanical heart dysfunction is common in diabetic patients (Demir et al., 2016).
Atrial fibrillation (AF) and ventricular arrhythmias (VAs) are the most common forms of
arrhythmias found in diabetic patients. Left ventricular diastolic dysfunction and
prolonged QTc of the ECG are also frequently reported in the diabetic heart.
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1.12.1 Metabolic alterations in type 1 diabetes mellitus
T1DM is an autoimmune disease characterized by autoreactive T cell-mediated
destruction of insulin-producing β-cells which leads to insulin insufficiency and
hyperglycemia. Changes occur in three major tissues: the liver, muscle and adipose tissues.
In the liver, increased liver glucose production, combined with decreased peripheral
utilization, leads to hyperglycemia. This is due to increased liver glucose metabolism and
reduced glucose absorption by insulin-sensitive glucose transporter (GLUT-4) in fat tissue
and muscles. To eliminate free fatty acids from fat tissue, the body develops ketosis which
results from massive mobilization of fatty acids from adipose followed by hepatic
ketogenesis with accelerated hepatic fatty acid β-oxidation and synthesis of 3hydroxybutyrate and acetoacetate. However, not all fatty acids are converted to ketones in
the liver, in fact some get converted into triacylglycerol which is packaged in very lowdensity lipoproteins (VLDL) and then secreted in the blood. On the other hand, some
diabetic patients have a lack of enzymes that are responsible for the degradation of
chylomicrons that are derived from food lipids by intestinal mucosal cells. For these
patients, the degradation of lipoprotein lipase enzyme will be inhibited, resulting in the
accumulation of chylomicrons in the blood, eventually the plasma chylomicron and VLDL
levels are elevated, resulting in hypertriacylglycerolemia (Figure 15) (Harvey & Ferrier,
2011).
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Figure 15: Metabolic alterations in type 1 diabetes mellitus. Adapted from (Harvey &
Ferrier, 2011).
1.12.2 Metabolic alterations in type 2 diabetes mellitus
In 2021, it was estimated that the number of adults (aged 20-79 years) with diabetes
was around 573 million and projected to reach 643 million by 2030, and 783 million by
2045. By 2021, about 6.7 million people will die of diabetes-related disease. About 319
million adults (6.7 percent of the global adult population) suffer from impaired fasting
glucose (IFG). It is estimated that 441 million adults, or 6.9 percent of the global adult
population, are expected to have IFG by 2045. (International Diabetes Federation, 2021).
Patients with T2DM differ from those with T1DM because they do not have total
destruction of the pancreatic cells, but instead, suffer from IR that affects three major
tissues of the body: the liver, muscle and adipose tissues. In IR, there is minimum ketosis
because insulin reduces liver ketogenesis. Dyslipidemias are similar to those with T1DM
with

increased

plasma

levels

of

VLDL

and

chylomicrons

resulting

in

hypertriacylglycerolemia, although lower plasma high density lipoproteins (HDLs) may
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also be present (Harvey & Ferrier, 2011). Figure 16 shows the metabolic changes which
occur in the body of a patient with T2DM.

Figure 16: Metabolic alterations in type 2 diabetes mellitus. Adapted from (Harvey &
Ferrier, 2011).

1.12.3 Complications of diabetes
Many cardiovascular risk factors are involved in diabetes, particularly T2DM.
Some of the risk factors include diabetes, hypertension, diet, obesity, smoking, decreased
exercise, genetics, and others that exacerbate cardiovascular symptoms of the disease
(Martín-Timón et al., 2014).
It is known that DM can cause short- and long-term complications caused by
damage to the blood vessels in various organs of the body. Some of these complications
include macrovascular diseases such as hypertension, hyperlipidemia, heart attacks,
coronary artery disease, strokes, cerebral vascular disease, and peripheral vascular disease
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and some include microvascular diseases including retinopathy, nephropathy, and
neuropathy (Khalil et al., 2018; Wu et al., 2014).

1.13 Obesity: Epidemiology and pathophysiology
Obesity is a serious global health problem and it is associated with metabolic
syndrome which has been described as the combination of IR, hypertension,
hyperlipidemia and obesity (Fellmann et al., 2013; Reaven, 1988). The World Health
Organization (WHO) (World Health Organization, 2018) defines obesity as “an abnormal
or excessive fat accumulation in adipose tissue, to the extent that health is impaired”. The
current gold standard classification of obesity is the Body Mass Index (BMI) which is
calculated as a person’s weight in kilograms divided by the square of height in meters
(kg/m2). For epidemiological reasons, a person is considered overweight if the BMI is
greater than 25 kg/m2 and obese if the BMI ≥ 30 kg/m2 (World Health Organization, 2018).
Excessive adiposity is a vital risk aspect in the pathophysiology of DM, IR, dyslipidemia,
atherosclerosis, hypertension, stroke, psychological, CAD, liver disease, osteoarthritis,
sleep apnea, some musculoskeletal conditions, gynecological complications, cancer
including colon and breast cancer (NHLBI Obesity Education Initiative Expert Panel.
National Institutes of Health. National Heart Lung and Blood Institute., 1998). Recently,
a new method of assessing body weight has been developed, called the Body Shape Index
(ABSI). It quantifies the risk associated with abdominal obesity. ABSI is based on waist
circumference (WC) and is adjusted for height and weight.

ABSI Equation 1:
ABSI = WC / (BMI (2/3) x height (1/2))
ABSI might be considered to be a more valuable predictor of mortality than BMI
(Krakauer & Krakauer, 2012). Obesity is considered a global health crisis, mainly because
of its remarkable increase in prevalence in recent decades. In 2016, about 1.9 billion adults
aged 18 and over worldwide were pre-obese or overweight, with estimates of more than
600 million adults being overweight. It is estimated that 13 percent of the world’s adult
population (11 per cent of men and 15 percent of women) are obese in 2016, meanwhile
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39 percent of adults aged 18 years and above (38 percent of men and 40 percent of women)
were overweight (World Health Organization, 2018). Between 1975 and 2016, global
obesity rates tripled, accounting for 30 percent of the world’s population. It is estimated
that 340 million children and adolescents aged 5-19 were obese or overweight in 2016, an
issue of extreme concern to governments around the world (World Health Organization,
2018). According to estimates from the latest Lancet Commission report, in 2015, obesity
affected 2 billion people worldwide and the annual cost was about $2 trillion from losses
in economic productivity and direct medical expenditure (Swinburn et al., 2019).
Obesity is a disorder resulting from a mixture of lifestyle, genetic and
environmental factors and has a multi-factorial basis. A sedentary lifestyle, reduction in
exercise or physical activity, reduced metabolic rate, thermal evolution and reduced
energy expenditure will ultimately lead to an increase in energy storage and obesity.
Causes of obesity include easy access to fast and addictive food, leptin resistance, junk
foods, assertive marketing of food, sedentary lifestyle, certain medications as well as
genetic factors. It is also worth noting that both overweight and obesity can be avoided.
Figure 17 shows some of the environmental and genetic factors that may contribute to
obesity and consequently, metabolic syndrome (Gurevich-Panigrahi et al., 2009).

Figure 17: Flow diagram showing the energy balance and etiology of obesity. Adapted
from (Gurevich-Panigrahi et al., 2009).
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Obesity is characterized by excess fat in the body and contributes significantly to
harmful metabolic effects. In addition, obesity is an important medical and socioeconomic burden. According to a recent report, the global cost of obesity treatment has
increased to a staggering 2 trillion USD (Dobbs & Swinburn, 2015; Swinburn et al., 2019).
Obesity is a consequence of an adverse increase in the mass of fat tissues resulting
from an increase in the size (hypertrophy) or number (hyperplasia) of fat cells. (F. C.
Howarth et al., 2017; Vasanji et al., 2004). These two events combine to orchestrate a
series of co-morbidities that lead to obesity. It is important to identify potential factors
regulating these processes of adipocyte biology in order to prevent and treat obesity.
Chronic energy imbalance leads to adipocyte hyperplasia and hypertrophy, stress
of endoplasmic reticulum, and mitochondrial dysfunction. These processes induce an
increase in intracellular and systemic release of adipokines, free fatty acids, and
inflammatory mediators that cause adipocyte dysfunction and adverse effects in the
pancreatic β-cells, liver, and skeletal muscles and more importantly, the heart itself, in
addition to the vascular beds (De Ferranti & Mozaffarian, 2008).
1.13.1 Obesity and the heart
According to the Framingham study, both overweight and obesity are associated
with an increased relative risk of developing cardiovascular risk factors and CVDs and
people with T2DM are 2/3 times more likely to develop CVDs (International Diabetes
Federation., 2017; Turpie et al., 2002).
The spread of APs depends on voltage-dependent ion channels, so it is helpful to
discuss these channels in more detail, because their dysfunction can cause CVDs. The
voltage-gated ion channels are important transmembrane proteins that control
physiological activities such as contraction and relaxation of heart muscle cells. Obese
Wistar rats fed a high fat diet demonstrate significant changes in gene expression of ion
channels in the left ventricle, which may predispose to arrhythmias. The heart of these
obese rats presents significant upregulation of various transport proteins including Cav1.2,
Kir2.1, HCN4, NCX1, SERCA2a, RYR2 mRNA and downregulation of ERG mRNA. In
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these obese rats, there was also a significant increase in HCN4 protein expression. (Ashrafi
et al., 2016).
Axelsen et al. (2015) demonstrated that the hearts of fructose-fat fed Sprague-Dawley rats
(FFFRs) displayed QRS prolongation in-vivo, along with decreased conduction velocity
(CV) ex-vivo. Similarly, the hearts of FFFRs rats revealed numerous premature ventricular
contractions (Axelsen et al., 2015) under relaxed conditions in-vivo. Likewise, the isolated
hearts from FFFRs displayed an increase in susceptibility to ventricular fibrillation (VF)
following cardiac ischemia-reperfusion. There were no changes in the coupling between
the gap junctions, the density of K+ or Na+ current, and the differences in cell size or
fibrosis. This indicates that the mechanism of conductance disturbances in the pre-diabetic
heart varies from the disturbances seen in cardiac ischemia and heart failure (HF) (Axelsen
et al., 2015). In another study, a high-energy (HE) diet consisting of 33% kcal as fat was
fed to Sprague-Dawley rats to create an experimental model of obesity. These rats did not
develop heart hypertrophy, whether at organ or cell level. In addition, the kinetics and
density of the four main ionic membrane currents that control heart AP were similar in
obese and control rats. These ionic currents included ICaL, INCX, the transient outward
potassium current and the delayed rectifier potassium current. Even though leptin receptor
(LepR) expression was downregulated in the hearts of the HE obese group, no leptin
modification was observed in the current densities except for the INCX densities in the
control group which were fed standard chow (Ricci et al., 2006).
In another study, Huang et al. (2013) found evidence of decreased protein
expression of voltage-gated K+ channels in the obese heart, leading to long QT interval.
Their experiments in diet induced obesity (DIO) C57BL/6J wild-type mice revealed that
diminished protein and mRNA levels of the potassium channel Kv1.5 were triggered by a
decline of the transcription factor cyclic-AMP response element binding protein (CREB)
in heart. CREB knock-down by siRNA diminished Kv1.5. CREB is linked to the Kv1.5
promoter in the heart and increases transcription of human and mouse Kv1.5 promoters.
The reduction in CREB proteins during lipotoxicity can be rescued by inhibiting protein
kinase D (PKD) (H. Huang et al., 2013).
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F. C. Howarth et al. (2012) previously reported age-dependent changes in myocyte
contractility in the hearts of young and ageing ZDF rats. These changes in contraction are
accompanied by changes in Ca2+ transport, including a decline in ICaL and subtle changes
in expression of a variety of genes including the Ca2+ channel, membrane transporters, SR
Ca2+ and cardiac muscle proteins (F. C. Howarth, 2012). However, DIO causes a heartupregulation of Ca2+ transport genes in SR. While obesity also causes an increase in the
levels of SERCA2a, RyR and phospholamban (PLB) mRNA, it did not modify the mRNA
levels of L-type Ca2+ channel (CACNA1C) and NCX in the hearts of Wistar rat (LimaLeopoldo et al., 2008). There were no changes in the L‐type Ca2+ channel protein levels
and SERCA2a behavior (expression and activity) (Leopoldo et al., 2011). Surprisingly, a
short period of high-fat diet (16 weeks) in Psammomys obesus, a polygenic model of
rodents, developed for research into obesity, T2DM and CVDs (Chaudhary et al., 2018),
led to severe changes in heart structure, activation of inflammatory and apoptotic
mechanisms and modification of expression of calcium cycle elements. (Sahraoui et al.,
2016). Aromolaran & Boutjdir et al. (2017) reviewed the literature for altered functional
expression of ion channels in various animal models associated with obesity and the data
are presented in Table 1.
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Table 1: Altered functional expression of ion channels in animal models. Adapted from
reference (Aromolaran & Boutjdir, 2017).

1.13.2 Animal models of obesity and their relevance to the heart
In order to study the mechanisms of heart remodeling in the context of obesity,
several animal models have been used over the years to study the function and dysfunction
of the heart. These models resemble obesity in humans, as well as comorbidities such as
IR, glucose tolerance failure, hypertension and diabetes. ZDF rats were isolated and
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derived from the ZF rat and are extensively used for obesity and T2DM research and will
be discussed in more detail later.
Storage of fat, especially in heart muscle, is associated with a reduction in the
production of cardiac force, which has negative hemodynamic consequences and
ultimately leads to HF. In addition, fats in the blood can be absorbed by heart muscle cells,
where they can be used to generate energy that can be stored or used in mitochondria.
Experiments in ZDF rats have shown that fat actually accumulates in the heart due to
increased transport across different membranes. Current experiments also show that lipids
accumulate in the heart despite normal mitochondrial content, morphology and oxidation
of long-chain fatty acids (LCFA) (Holloway et al., 2011). In addition, increased transport
rates of LCFA and LCFA protein result in a larger number of lipid drops stored in heart
muscle (Holloway et al., 2011).
Obesity is associated with high blood pressure (BP), which increases the risk of
CVDs. Simonds et al. (2014) observed that the increase in leptin levels observed in DIO
promotes an increase in BP in rodents, an outcome that was not previously seen in leptin
deficient or LepR deficient animals. Similarly, humans, with a loss in function of
mutations in leptin and LepR, have reduced BP despite severe obesity. This fascinating
observation indicates that leptin is linked with changes in body weight in both human and
mammals leading to an alteration in BP. Thus, leptin and LepR effects are essential for
diabesity and can be used to establish useful therapeutic targets for the prevention and
treatment of obesity-associated hypertension and/or obesity-associated CVDs (Simonds et
al., 2014).
In a study in ZL, ZF and Sprague-Dawley rats Lin et al. (2015) examined the SAN
to test for the function of specific behaviors of leptin on heart rate (HR) and ventricular
repolarization. They discovered that adipocytes and LepR were present in the myocardium
and as a result, it was speculated that leptin could directly alter the electrical properties of
the heart such as HR and QT intervals and that it can control cardiac electrical activity via
the activation of the β-adrenergic receptor (β-AR). These findings suggested that leptin, at
high doses (150–300 μg/kg), can stimulate a biphasic effect (decrease followed by an
increase) in HR while at low doses (0.1–30 μg/kg), it can decrease resting HR. Resting
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HR inhibition induced by leptin was abolished by the presence of a leptin antagonist.
Leptin also corrected QTc interval time and increased HR. However, leptin antagonist did
not change these two parameters. It was also reported that in isolated ventricular myocytes,
leptin (0.03–0.3 μg/ml) increased the APD and the effects were reversible. Leptin has a
direct effect on the reduction of HR and the increase of QT interval by its own receptor
and independently of β-AR stimulation. Moreover, high concentrations of leptin in the
myocardium can produce long QT intervals, deep bradycardia, and VA by inhibiting the
activity of the β-AR (Lin et al., 2015). We will discuss our investigation of β-AR in chapter
7.

1.14 Relationship between obesity and type 2 diabetes mellitus
Obese people are more likely to develop T2DM and obesity is an independent and
important metabolic marker of T2DM. T2DM, induced by obesity, is usually referred to
as metabolic syndrome or IR, or pre-diabetes that leads to a high blood glucose level. In
this condition, the body synthesizes and releases sufficient insulin in the blood, but the
cells of the body have become resistant to the effects of insulin (Weyer et al., 2001).
In recent years, scientists have developed a new T2DM rat model, the ZDF rat
(Yokoi et al., 2013). This model is naturally obese and develops T2DM and inflammation.
As such, it is an ideal model to understand how obesity-induced T2DM can lead to DCM.
Due to the strong connection between obesity and diabetes, the term “diabesity”
was created. Although the majority of T2DM patients are obese, only a relatively small
proportion of obese people develop T2DM (Zimmet et al., 2001). The molecular
mechanisms proposed to explain these complications are not yet well understood. Figure
summarizes the three main hypotheses which have been developed in recent years to
explain the molecular basis of diabesity (Chadt et al., 2000) and they include the following:
1. The “inflammation hypothesis” suggests that obesity represents a state of chronic
inflammation where inflammatory molecules released by the infiltration of macrophages
into adipose tissue cause pathological changes in β-cells and insulin-sensitive tissues such
as the endocrine glands, the muscles, the endocrine pancreas, and the liver.
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2. The “lipid overflow hypothesis” suggests that obesity may lead to an increase in ectopic
lipid storage, as obese people have limited fat storage capacity in fat tissues. These
potentially harmful lipid components and metabolites can be used to stimulate cytotoxicity
of peripheral cells of the pancreas, muscles, and liver.
3. The “adipokine hypothesis” suggests that the main role of white fat cells is to function
as an endocrine organ and secrete a range of hormones with autocrine and paracrine
activity. Diabesity enlarging fat reserves can cause the dysfunctional secretion of these
endocrine factors, thus resulting in metabolic impairment of insulin target tissues and
ultimately failure of insulin producing β-cells. Moreover, these adipokines have direct
effects on the muscles, the central nervous system (CNS) and the liver.

(A)

Figure 18: Three main hypotheses that link obesity and diabetes. (A) Inflammation.
Adapted from (Chadt et al., 2000).
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(B)

(C)

Figure 18: Three main hypotheses that link obesity and diabetes. (B) Lipid overflow and
(C) adipokines. Adapted from (Chadt et al., 2000) (Continued).
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Obesity is correlated with various disorders such as hypertension, sleep apnea
syndrome, atherosclerosis, and CAD. Obesity also precedes changes in the structure and
function of the heart and ultimately leads to HF. Obesity can cause changes in myocardial
structure and increase the risk of ventricular fibrillation or HF, as well as sudden cardiac
death (SCD) (Csige et al., 2018). That is why it is important to investigate the effects of
obesity on the heart and its relationship to DCM.

1.15 Development of diabetic cardiomyopathy
More than 80% of obese patients die from DCM. As such, it is important to
understand this disease, including several risk factors such as hyperlipidemia, high BP,
diet, obesity, smoking, reduced physical activity and genetics as well as the development
of DCM in T2DM (Mortuza & Chakrabarti, 2014; Schaffer, 1991). It is known that DM
can cause both short- and long-term complications due to damage of blood vessels in
various organs of the body. Some of these complications include macrovascular diseases
such as high blood pressure, high cholesterol, heart attack, CAD, stroke, cerebral vascular
disease and peripheral vascular disease. Other complications include microvascular
diseases such as retinal, nephrological, and neurologic diseases. Macrovascular
complications and, to a lesser extent, microvascular complications such as nephropathy
can lead to DCM (Falcão-Pires & Leite-Moreira, 2012; Isfort et al., 2014; Murarka &
Movahed, 2010). DCM is a major adverse complication of T2DM characterized by
diastolic and systolic dysfunction. In T2DM, factors contributing to DCM include a
defective regulation of Ca2+ cell homeostasis due to the dysregulation of calcium transport
proteins in cells. First, there is a significant impairment in sarcolemmal NCX activity,
limiting the ability of the diabetic heart to extrude Ca2+ leading to an elevation in diastolic
[Ca2+]i. Second, there is a decrease in Na+/K+ ATPase activity, which is known to increase
[Ca2+]i secondary to a rise in [Na+]i. Third, Ca2+ influx via the Ca2+ channel is stimulated
(Schaffer, 1991). Fourth, SERCA activity is reduced in diabetic hearts and fifth, the RyR
becomes desynchronized leading to elevated diastolic calcium (H. Huang et al., 2017;
Snyders, 1999). In addition, the dysfunction of vascular endothelial cells and cardiac
endothelial cells can also contribute to the pathogenesis of DCM leading to oxidative
stress, elevation in methylglyoxal (MG), fibrosis, hypertrophy and remodeling of the heart
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(Matafome et al., 2017; Mortuza & Chakrabarti, 2014). Since DCM is a major hallmark
of diabetes, including both T1DM and T2DM and since obesity also plays a role in the
development of T2DM, then it is important to ascertain how obesity-induced DM, as in
the model of ZDF rats, can induce DCM. Therefore, it is important to understand the
development of the ZDF model and what is currently known about DCM in this model.

1.16 Aims and Objectives
[1] To explore the general characteristics of ZDF and ZF compared to ZL rats.
[2] To explore the effects of obesity and diabesity on the electrical conduction system of
the heart using in-vivo biotelemetry techniques in ZDF and ZF compared to ZL rats.
[3] To explore the effects of obesity and diabesity on the electrical conduction system in
the isolated perfused heart using an extracellular suction electrode in the ZDF and ZF
compared to ZL rats.
[4] To explore the effects of obesity and diabesity on ventricular myocyte shortening using
cell imaging in the ZDF and ZF compared to ZL rats.
[5] To explore the effects of obesity and diabesity on ventricular myocyte Ca2+ transport
using fluorescence photometry techniques in the ZDF and ZF compared to ZL rats.
[6] To explore the effects of obesity and diabesity on ventricular myocyte Ca2+ transport
using whole-cell patch clamp techniques in the ZDF and ZF compared to ZL rats.
[7] To explore the effects of Isoprenaline (ISO) on obesity and diabesity on ventricular
myocyte shortening and Ca2+ transport using cell imaging and fluorescence photometry
techniques in the ZDF and ZF compared to ZL rats.
[8] To explore the effects of obesity and diabesity on the expression of proteins and
structure of ventricular muscle using Western blot and Transmission electron microscope
(TEM) techniques in the ZDF and ZF compared to ZL rats.
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Chapter 2: Investigating the general characteristics of ZDF and ZF
compared to ZL rats
2.1 Introduction
The ZF rat inherits obesity as an autosomal Mendelian recessive trait. ZDF rats
originated from ZF and are widely used in T2DM research. ZF rats have a mutation (fatty,
fa) in the LepR gene which leads to excessive eating or hyperphagia and the development
of obesity without DM. A missense mutation (conversion A to C in nucleotide position
806) was found in the extracellular domain of all isoforms in ZF rats (fa/fa), which resulted
in an amino acid change from glycine (Gln) to proline (Pro) at +269. The obese mouse
named the “ob/ob” mouse model was discovered in 1949 at the Jackson laboratories in
Maine (Ingalls et al., 1950). It was later hypothesized by Jeffrey Friedman that the
responsible gene was Leptin (as of the Greek term Lepto signifying thin) (Friedman, 2012,
2016; Neill, 2013). Leptin is a versatile 16 kDa peptide hormone which is secreted by fat
cells with various actions, one of them is controlling hunger and satiety (Frühbeck, 2006).
These (OB-R) leptin receptor isoform mRNAs are present in the brain from ZF (fa/fa) rats
at similar amounts to those in their lean littermates (ZL) (Takaya et al., 1996). ZF rats are
obese, hyper-insulinemic and hyperphagic, but blood glucose remains at normal levels.
Hypertriglyceridemia in these animals is usually due to increased liver production of
VLDL. Adipocytes increase in number and size and, in general, subcutaneous fat stores
have the largest number of fat cells. The lipogenesis of glucose occurs abruptly in young
animals but decreases with age. Enzymatic patterns of glycolysis and gluconeogenesis
seem to reflect a changed internal environment, rather than specific defects. Endocrine
changes in fatty rats include a reduction in glucagon levels, hyperinsulinemia, and
hypothyroidism, and during their first introduction they had defective reproductive
function (Bray, 1977).
From a ZF rat colony (Yokoi et al., 2013), a new strain of homozygous male rats
fa/fa with reproductive capability was found by mating male fa/fa and heterozygous fa/+
female. This new fa/fa male rat strain showed DM-selective breeding and showed
relatively high blood sugar levels at 10 weeks of age which resulted in the establishment
of a diabetic strain that was designated: ZDF -Lepr 𝑓𝑎. These fa/fa male heterogeneous
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rats developed DM at the age of 10 weeks and all the rats had DM at the age of 21 weeks,
while none of the male fa/+ rats developed DM. The phenotypical characteristics of this
diabetic species differ from those of normal-glycemic ZF rats. Several studies have shown
progressive functional and structural changes in the heart and kidneys from 16 weeks,
without evidence that one pathology precedes or causes the other in ZDF rats (Baynes &
Murray, 2009). The highly reproductive ZDF rats provide a useful animal model of T2DM
(Yokoi et al., 2013).

2.2 Aims and objectives
• To investigate the characteristics of ZDF and ZF compared to ZL control rats in
terms of their body weight, heart weight, non-fasting glucose and their plasma insulin
levels.
• To investigate the differences in glucose tolerance in ZDF and ZF compared to ZL
control rats.

2.3 Methods
Ethical consent for this research project was acquired from the UAE University
Animal Research Ethics Committee and experiments were executed in agreement with
institutional guidelines.
Four different batches (10 each) of Male Zucker rats (40 ZF, 40 ZDF, 40 ZL) were
purchased from Charles River (USA) aged 28–34 days on the day of their arrival and
housed in our animal facility. Rats were housed individually and received water and
standard rat chow ad libitum. The temperature was maintained at (22–24°C) and rats were
exposed to a 12/12-hour light/dark cycle. The following Table 2 provides the detailed
composition of the standard chow animal feed.
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Table 2: Standard Chow Animal feed.
Animal Feed
Rats & Mice Feed (12 mm Pellets)
(Diet-A feed pellets)
Each Sack - 50 Kg
Food Composition:
C. Protein

24% min

C. Fiber

5% Max

C. Ash

8% Max

Calcium

1% Min

Phosphorus

0.75% Min

From Vitamin Premix
A

IU/Kg

14500

D

IU/Kg

4500

25-OH Vit D

µg/Kg

68.75

E

mg/Kg

111.67

K3

mg/Kg

3.3

Thiamine (B1)

mg/Kg

3.175

Riboflavin (B2)

mg/Kg

9.15

Pantothenic Acid

mg/Kg

18.12

Pyridoxine (B6)

mg/Kg

8.5

Biotin

µg/Kg

245

Niacin

mg/Kg

95.039

Folic Acid

mg/Kg

2.175

Cyanocobalamin

µg/Kg

25

Note:
The animal feed was supplied by the Abu Dhabi Animal Flour
and Feed Factory, Abu Dhabi

Body weight and blood glucose (OneTouch Ultra 2, LifeScan) were measured
periodically during the study. Glucose tolerance tests (GTTs) were administered just
before the start of every experiment for each batch of animals. Blood was taken from the

64

rat tail vein of the non-anesthetized rats. Following an overnight fast the fasting blood
glucose (FBG) was determined. Animals were then injected with glucose (2g kg−1 body
weight, intraperitoneal) and blood glucose was measured at 30, 60, 120 and 180 minutes
after glucose injection.
Insulin is the primary hormone responsible for the control of glucose metabolism.
It is synthesized in the β-cells of the islets of Langerhans. Proinsulin which is the precursor
to insulin is processed to form C-peptide and insulin which are then secreted into the portal
circulation in equimolar amounts. The mature insulin consists of 51 amino acids that
comprises two polypeptide chains, the A and B chains which are linked together by two
inter-chain disulphide bridges. The A chain also has an intra-chain disulphide bridge. The
main function of insulin is to control the uptake and utilization of glucose in peripheral
tissues via the glucose transporter (Figure 19) (Harvey & Ferrier, 2011).

Figure 19: Insulin. (A) Structure of insulin and (B) formation of insulin. Adapted from
(Harvey & Ferrier, 2011).
At the time of the experiments and during the sacrifice of the rats the blood was
collected from the neck of the decapitated head in Ethylenediaminetetraacetic acid
(EDTA) coated glass tubes which is an anticoagulant to prevent blood from clotting
(Nguyen & Wahed, 2013), then it was centrifuged at 400 revolutions per minute (RPM)
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(Centurion Scientific, C2 series) for 5 minutes and the supernatant blood plasma was
removed then stored at -80ºC for insulin ELISA measurements. A commercially available
rat insulin ELISA kit (10-1250-01, Mercodia AB, Sweden) was used. It is a solid phase
two-site enzyme immunoassay based on the direct sandwich technique in which two
monoclonal antibodies are directed against separate antigen determinants on insulin.
During incubation insulin in the sample reacts with peroxidase-conjugated anti-insulin
antibodies and anti-insulin antibodies bound to the microtiter well. During washing the
unbound enzyme labeled antibody is removed. Then the bound conjugate is detected by
reacting with 3,3’,5,5’-tetramethylbenzidine. The reaction is stopped by adding acid to
give a colorimetric endpoint that is read using a spectrophotometer.

2.4 Statistics
Results were presented as the mean ± standard error of mean (SEM) of n
observations. Statistical comparisons were done by IBM SPSS and Origin 9.0 (OriginLab,
Northampton, Massachusetts, USA) statistics software using either the independent
samples t-test or one-way ANOVA and then by Bonferroni corrected t-tests for multiple
comparisons, as appropriate. P values of 0.05 and less were considered statistically
significant.

2.5 Results
The general characteristics of the ZL, ZF and ZDF rats are shown in
Table 3. The ZF and ZDF groups exhibited significantly (p<0.05) increased body weight
and heart weight compared to ZL rats. Non-fasting blood glucose was significantly higher
in ZDF (384.44±20.28 mg/dl) compared to ZF (140.00±4.58 mg/dl) and ZL (118.25±2.62
mg/dl) rats. Non-fasting blood glucose was not significantly (p>0.05) different between
ZF and ZL rats. Heart weight / body weight ratio was increased in ZF (3.27±0.09 g/mg)
rats compared with (ZL 2.71±0.07 g/mg) and ZDF (2.79±0.05 g/mg). Insulin was
measured by ELISA in blood plasma using a commercially available rat insulin ELISA kit
(10-1250-01, Mercodia rat Insulin ELISA). ZF (12.70±1.15 µg/L) had significantly
(p<0.05) higher insulin levels compared to ZL (2.09±0.57 µg/L) and ZDF (2.14±0.29
µg/L) rats and these results are similar to a previously published study (Chohnan et al.,
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2020).

Table 3: General characteristics of Zucker rats.

Body weight
(g)
Heart weight
(g)
Non-fasting
blood Glucose
(mg/dl)
Heart weight/
Body weight
ratio (mg/g)
Plasma
Insulin (µg/L)

ZL (n)

ZF (n)

ZDF (n)

439.82±6.46 (33)

695.85±14.30 (33)*

558.83±21.44 (36)*#

1.66±0.05 (33)

2.15±0.05 (33)*

2.00±0.06 (36)*

118.25±2.62 (32)

140.00±4.58 (33)

384.44±20.28 (36)*#

2.71±0.07 (33)

3.27±0.09 (33)*

2.79±0.05 (36)#

2.09±0.57 (10)

12.70±1.15 (9)*

2.14±0.29 (8)#

Data are mean ± SEM, number of animals is in parenthesis. P values of 0.05 and less were
considered statistically significant. * p<0.05 compared to ZL, # p<0.05 compared to ZF.
The glucose tolerance test was performed just before commencement of
experiments (Figure 20). The fasting blood glucose was highest in ZDF (223.4±12.86
mg/dL, n=35), intermediate in ZF (133.53±2.99 mg/dL, n=34) and lowest in ZL
(94.55±1.59 mg/dL, n=33) rats and these differences were significant (p<0.05). At 180
minutes following the glucose challenge, blood glucose remained significantly elevated
(p<0.05) in ZDF (373.97±23.86 mg/dL, n=33) and ZF (212.29±14.43 mg/dL, n=34) in
contrast to ZL (113.88±4.32 mg/dL, n=33-35) control rats.
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Figure 20: Glucose tolerance test. Data are mean ± SEM, n=33 ZL, 34 ZF and 33-35 ZDF
rats. Numbers in parenthesis represent significant differences. P values of 0.05 and less
were considered statistically significant.

2.6 Discussion
ZDF and ZF rats were characterized by increased body weight and heart weight
compared to ZL rats and ZDF rats had elevated non-fasting blood glucose compared to
ZF and ZL rats. Heart weight/body weight ratio was highest in ZF compared to ZL and
ZDF rats. Fasting blood glucose was highest in ZDF, intermediate in ZF and lowest in
ZL rats. At 180 minutes, following the glucose challenge, blood glucose was still
significantly elevated in ZDF and in ZF compared to ZL rats. It was interesting to find
that blood insulin was significantly raised in ZF rats but not in ZDF rats compared to ZL
rats however, these findings are consistent with previous studies (Chohnan et al., 2020;
Jonas et al., 2005). Another study reported raised fasting serum glucose, insulin,
cholesterol and triglyceride and impaired glucose tolerance in ZDF rats (Sárközy et al.,
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2013). These results might be explained by considering the mechanisms involved in
insulin signaling and degradation. The ratio of the bound and unbound insulin to its
receptors could be compromised in ZF rat. Insulin signaling starts with binding to a
tyrosine

kinase

receptor

called

insulin

receptor

kinase

(IRK).

Following

autophosphorylation, it is internalized into the endosomal system (ENS) where it is
activated to tyrosine phosphorylate key cellular substrates which then recruit glucose
transporters from intracellular stores in skeletal, cardiac muscle and adipose tissue which
in turn activates various biological processes. Degradation of insulin is controlled by
intra-endosomal acidification, in which “insulinase” promotes the dissociation of insulin
from the IRK. This degradation may also be compromised in the ZF rat (Harvey &
Ferrier, 2011; Posner, 2017). The observed increase in the body weight is consistent with
the hyperphagia seen in ZDF and ZF rats. Previous studies have reported similar changes
in FBG, GTT and RBG and serve to demonstrate the relationship between obesity and
diabesity on glucose metabolism (Di Nardo et al., 2015; F. C. Howarth et al., 2011, 2012;
López-Soldado et al., 2016).

2.7 Conclusions
• Non-fasting and fasting blood glucose was significantly elevated in ZDF compared to
ZF and ZL rats.
• Heart weight / body weight ratio was increased in ZF rats compared with ZL and
ZDF.
• ZF rats had significantly higher insulin levels compared to ZDF and ZL rats.
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Chapter 3: Investigating the electrical conduction system using in-vivo
biotelemetry techniques in the ZDF and ZF compared to ZL rats
3.1 Introduction
There is currently limited research on ECG measurement and assessment in ZDF
rats. Early signs of diabetic autonomic neuropathy in the ECG include widening of QTc
interval, elevated R wave amplitude (AMP) and decreased heart rate variability (HRV)
which is a measure of the autonomic nervous system and discussed below. The severity of
neuropathy is directly related to the risk of mortality. Aerobic exercise training (AET) is
a common recommendation for postponing and possibly reversing cardiac dysfunction. A
previous study demonstrated alterations in R wave AMP, HRV, QT and QTc intervals in
ZDF rats. AET had beneficial effects and was able to correct the changes in the AMP of
the R wave as well as ECG correlates of the left ventricle mass (VanHoose et al., 2010).
SAN from the right atria of male obese and ZL rats, male Sprague-Dawley, as well
as the ventricles of male Sprague-Dawley rats have been used to investigate the direct
actions of leptin on HR and ventricular repolarization. Since LepR and adipocytes are
present in the myocardium, it has been proposed that Leptin modulates the electrical
properties of the heart through activation of the β-AR and that it can directly regulate
cardiac electrical properties such as HR and QT interval through its receptor. The results
from the study showed that leptin, at low doses (0.1–30 μg/kg), decreased resting HR while
at high doses (150–300 μg/kg), it produced a biphasic effect (decrease followed by an
increase) on HR. The leptin-induced inhibition of resting HR was fully reversed by leptin
antagonist. Leptin also increased HR and corrected QTc interval, however, leptin
antagonist did not reverse these two parameters. In isolated ventricular myocytes, leptin
(0.03–0.3 μg/ml) reversibly increased the APD. In summary, leptin can directly increase
QT interval and decrease HR through its receptor independent of β-AR stimulation.
During inhibition of β-ARs, higher concentrations of leptin in myocardial cells can cause
deep bradycardia, delayed QT intervals and VAs (Lin et al., 2015).
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3.2 Hypothesis
• Defects in electrical transmission partly underlie electro-mechanical dysfunction in
the ZDF and ZF rat heart.

3.3 Aims and objectives
• The general aim was to explore the effects of obesity and diabesity on the electrical
conduction system using in-vivo biotelemetry techniques in the ZF and ZDF compared
to ZL control rats.
• The specific aims were to investigate the effects of obesity and diabesity on HR,
physical activity, body temperature and ECG in the ZDF and ZF compared to ZL
control rats.

3.4 Methods
Biotelemetry experiments in ZF, ZDF and ZL rats were performed according to
previously described techniques (F. C. Howarth et al., 2008). Heart biopotential, body
temperature and physical activity were monitored with a biotelemetry system (Data
Sciences Int.). The biotelemetry system consisted of the transmitter devices (TA11CTAF40, Data Sciences Int.), the receivers (RPC-1, Data Sciences Int.), a data exchange matrix
(20CH, Data Sciences Int.) and a personal computer for system acquisition, control,
configuration and data storage. The transmitter devices were implanted in 10 ZF, 10 ZDF
and 10 ZL rats at 70–75 days of age, under general anesthesia (sodium pentobarbitone,
45–55 mg kg−1, intraperitoneal). The transmitter devices were surgically implanted into
the peritoneal cavity and electrodes from the transmitter were arranged in Einthoven
bipolar lead II configuration (right foreleg and left hind leg) and recording was continued
up to 195 days of age as shown in Figure 21.
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Figure 21: Biotelemetry system. Top left panel: configuration of receivers. Top right
panel: electrodes configuration (lead II). Bottom left panel: transmitter next to anesthetized
animal. Bottom right panel: rats in separate cages on top of the receivers.
3.4.1 Biotelemetry data collection and analysis
ECG, body temperature, and physical activity data were collected for 5 minutes per
hour per animal, 24 hours per day, and 7 days per week for the full duration of the 6.5month study. From the collected ECG data, secondary physiological measurements were
determined, including the average 5-minute PQ, QRS, QT, QTc, HR, average 24-hour
HRV and HRV power spectral density (PSD). The PQ interval was identified as the time
from the beginning of the P wave to the beginning of the QRS complex. The QRS duration
was the time from the start to the end of the QRS complex. The QT was measured as the
time from the onset of the QRS to the end of the T-wave. QTc is the HR adjusted QT
interval. The average 5-minute PQ, QRS, QT, and QTc intervals were determined using
the Physiostat ECG Analysis application (Data Sciences Int.). The PQ, QRS, and QT
intervals were defined as the per-beat time between each of the ECG locations. The QTc
was defined as corrected QT interval whereby the Bazett algorithm was implemented by
dividing each QT interval by the square root of the associated R-R interval. The 5-minute
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average HR was determined from the average normal-to-normal R-wave interval and then
converted to beats per minute (BPM). The HRV was computed over 24 hours as the
standard deviation of the average normal-to-normal HR, which is termed the SDANN
(Task Force, 1996). To estimate the 24-hour HRV PSD, first the normal-to-normal R-wave
intervals were computed for each 5-minute ECG. Then, each 5-minute strip was
interpolated to 0.1 seconds equally spaced data with the average suppressed. Then the
Burg Method was used to estimate the normalized PSD of each 5-minute strip, by
determining the Fourier transform of the least squares, autoregressive model. Power
normalization was implemented by dividing each spectral estimate by the sum total. Since
the 5 minutes, beat-to-beat HRV signal had been interpolated to 0.1 seconds, the PSD
frequencies ranged from 0 to 5 Hz, as per the Nyquist sampling criteria. Lastly, 24
consecutive PSD estimates were averaged to determine the 24-hour HRV PSD estimate
per animal. From the 24-hour HRV PSD, the low frequency (LFq) and high frequency
(HFq) ranges were set by inspection and computed as the magnitude total between 0.5-1.5
Hz and 2.5-3.5 Hz, respectively. The LFq/HFq ratio was also computed (F. C. Howarth et
al., 2005). An example of our acquisition software (Data Sciences Int.) is shown in Figure
22.

(A)

Figure 22: Acquisition software (Data Sciences Int.). (A) Sampling and acquisition
summary.
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(B)

Figure 22: Acquisition software (Data Sciences Int.). (B) Typical ECG records
(Continued).

3.5 Statistics
Two-way repeated measures ANOVA was used to investigate the effect of group
(ZDF, ZF and ZL rats), age (105, 135, 165 and 195 days of age) and the interaction of
group and age on HR, HRV and other physiological parameters. Repeated measures
ANOVA was used because the same unit was observed at four different time points. The
main assumptions of the repeated measure ANOVA were tested for each outcome. The
normality assumption was tested using the Shapiro-Wilk test, and the sphericity
assumption was tested using the Mauchly's test. Additionally, the Independent Samples t
Test was used to further analyze the differences, in HR and other physiological parameters,
between the groups at each age and the Paired Samples t Test was used to further analyze
the differences, in HR and other physiological parameters, between the different ages for
each group. P values of 0.05 and less were considered statistically significant.
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3.6 Results
3.6.1 Biotelemetry physical activity results
Physical activity was determined by measuring changes in the animal’s transmitter
signal strength. Specifically, the transmitter signal strength was sampled at 64 Hz and
calibrated to counts per minute (CPM). When the animal changed position, the
corresponding transmitter signal strength changed, which resulted in a change in CPM.
Low counts indicate reduced physical activity in the animal. The continuous average
physical activity in ZDF, ZF and ZL groups for the 4-month study is shown in Figure 23A.
There were some significant (p<0.05) differences in mean physical activity between the
groups and ages of the rats as shown in Figure 23B. At 195 days, the physical activity was
(1.41±0.20 CPM, n=10 in ZL), (1.38±0.15 CPM, n=10 in ZF) and (1.65±0.11 CPM, n=10
in ZDF) rats; however, these differences in physical activity were not significant (p>0.05)
(Figure 23B).
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Figure 23: Physical activity. (A) Continuous mean physical activity recorded throughout
the study and (B) mean physical activity at 105, 135, 165 and 195 days. Data are mean ±
SEM, n=10 ZL, 10 ZF, and 10 ZDF rats. P values of 0.05 and less were considered
statistically significant.
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3.6.2 Biotelemetry body temperature results
The animal body temperatures were measured hourly. The continuous average
body temperature in ZDF, ZF and ZL rats for the 4-month study are shown in Figure 24A.
There were some significant (p<0.05) changes in mean body temperature between groups
and ages of the rats as shown in Figure 24B. At 195 days the body temperature was
(37.24±0.12°C, n=10 in ZL), (37.18±0.11°C, n=10 in ZF) and (37.45±0.10°C, n=10 in
ZDF) rats and the differences were not significant (p>0.05) (Figure 24B).
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Figure 24: Body temperature. (A) Continuous mean body temperature recorded
throughout the study and (B) mean body temperature at 105, 135, 165 and 195 days. Data
are mean ± SEM, n=10 ZL, 10 ZF, and 10 ZDF rats. P values of 0.05 and less were
considered statistically significant.
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3.6.3 Biotelemetry heart rate
The HR was determined from the 5-minute average of all normal R-wave to Rwave intervals in the ECG. The continuous group average HR for ZDF, ZF and ZL rats
over the 4-month study is shown in Figure 25A. There were some significant (p<0.05)
changes in mean HR between the groups and the ages of the rats as shown in Figure 25B.
At 195 days, HR was significantly (p<0.05) lower in ZDF (265±8 BPM, n=10) compared
to ZF (336±9 BPM, n=10) and ZL (336±10 BPM, n=10) rats. HR was 21% lower in ZDF
compared to ZF and ZL rats (Figure 25B).
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Figure 25: Heart rate. (A) Continuous mean heart rate recorded throughout the study and
(B) mean heart rate at 105, 135, 165 and 195 days. Data are mean ± SEM, n=10 ZL, 10
ZF, and 10 ZDF rats. P values of 0.05 and less were considered statistically significant.

80

3.6.4 Biotelemetry heart rate variability
The HRV was computed over 24 hours as the SDANN. The continuous group
average HRV for ZDF, ZF and ZL rats over the 4-month study is shown in Figure 26A.
There were some significant (p<0.05) changes in mean HRV between the groups and the
ages of the rats as shown in Figure 26B. At 195 days HRV was lowest in ZDF (22±1 BPM,
n=10), intermediate in ZF (27±1 BPM, n=10) and highest in ZL (31±1 BPM, n=10) rats.
The differences were significant (p<0.05) (Figure 26B).
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Figure 26: Heart rate variability. (A) Continuous mean heart rate variability recorded
throughout the study and (B) mean heart rate variability at 105, 135, 165 and 195 days.
Data are mean ± SEM, n=10 ZL, 10 ZF, and 10 ZDF rats. P values of 0.05 and less were
considered statistically significant.
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3.6.5 Electrocardiogram
3.6.5.1 PQ Interval
The continuous group average PQ interval for ZDF, ZF and ZL rats over the 4month study is shown in Figure 27A. There were some significant (p<0.05) changes in
mean PQ interval between the ages of rats as shown in Figure 27B. At 195 days, PQ
interval was not significantly changed (p>0.05) in ZDF (46.25±1.10 msec, n=10)
compared to ZF (45.22±0.88 msec, n=10) and compared to ZL (44.13±1.09 msec, n=10)
rats (Figure 27B).
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Figure 27: PQ interval. (A) Continuous PQ interval recorded throughout the study and (B)
mean PQ interval data at 105, 135, 165 and 195 days. Data are mean ± SEM, n=10 ZL, 10
ZF, and 10 ZDF rats. P values of 0.05 and less were considered statistically significant.
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3.6.5.2 QRS complex
The continuous group average QRS complex for ZDF, ZF and ZL rats over the 4month study is shown in Figure 28A. There were some significant (p<0.05) differences in
QRS interval between groups and the ages of the rats as shown in Figure 28B. At 195
days, the QRS complex was not significantly changed (p>0.05) in ZDF (19.13±0.48 msec,
n=10) compared to ZF (17.56±0.24 msec, n=10) and compared to ZL (18.25±0.59 msec,
n=10) rats (Figure 28B).
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Figure 28: QRS interval. (A) Continuous QRS interval recorded throughout the study and
(B) mean QRS interval data at 105, 135, 165 and 195 days. Data are mean ± SEM, n=10
ZL, 10 ZF, and 10 ZDF rats. P values of 0.05 and less were considered statistically
significant.
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3.6.5.3 QT and QTc interval
The continuous group average QT and QTc interval for ZDF, ZF and ZL rats over
the 4-month study are shown in Figure 29A & Figure 30A. The group average QT and
QTc for ZL, ZF and ZDF rats at selected time points are shown in Figure 29B & Figure
30B. There were some significant (p<0.05) changes in QT and QTc intervals between
groups and ages of rats as shown in Figures 29F and 30H. At 195 days, the QT interval
was not significantly changed (p>0.05) in ZDF (71.88±3.97 msec, n=10) compared to ZF
(74.11±1.88 msec, n=10) and compared to ZL (67.88±1.78 msec, n=10) rats (Figure 29B).
After correction for HR rate the QTc interval at 195 days was significantly (p<0.05)
increased in ZF (171.78±5.56 msec, n=10) compared to ZDF (148.75±8.90 msec, n=10)
rats (Figure 30B).
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Figure 29: QT interval. (A) Continuous QT interval recorded throughout the study and (B)
mean QT interval data at 105, 135, 165 and 195 days. Data are mean ± SEM, n=10 ZL, 10
ZF, and 10 ZDF rats. P values of 0.05 and less were considered statistically significant.
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Figure 30: QTc interval. (A) Continuous QTc interval recorded throughout the study and
(B) mean QTc interval data at 105, 135, 165 and 195 days. Data are mean ± SEM, n=10
ZL, 10 ZF, and 10 ZDF rats. P values of 0.05 and less were considered statistically
significant.
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3.6.6 Heart rate variability power spectral density
To further characterize the group differences on autonomic control of HR the group
24-hour HRV PSD was analyzed. Group HRV PSD at 105, 135, 165 and 195 days of age
are shown in Figure 31A-D. At each of the time points, there was a small increase in
normalized HRV PSD at LFs and a larger reduction in normalized HRV PSD at HFqs in
ZDF compared to ZF and ZL rats (Figure 31A-D). There were some significant changes
(p<0.05) in HRV at LFq, HFq and LFq/HFq between groups and age of rats as shown in
Figure 31E, 31F and 31G. At 105, 135 and 165 days, there were significant (p<0.05)
differences within groups. At 195 days of age, there were no significant changes (p>0.05)
within groups in HRV at LFq (Figure 31E). At HFq there were significant (p<0.05) and
progressive reductions in HRV in ZDF rats compared to ZF and ZL rats at 135, 165 and
195 days of age (Figure 31F). At 135, 165 and 195 days the LFq/HFq was significantly
higher (p<0.05) in ZDF compared to ZF and ZL rats (Figure 31G).
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Figure 31: Spectral density analysis. Group heart rate variability, normalized power
spectral density at (A) 105 and (B) 135.
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Figure 31: Spectral density analysis. Group heart rate variability, normalized power
spectral density at (C) 165 and (D) 195 days (Continued).
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Figure 31: Spectral density analysis. (E) Mean group heart rate variability, normalized
power spectral density, across the LFq range of 0.5– 1.5 Hz and (F) HFq range of 2.5– 3.5
Hz (Continued).
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Figure 31: Spectral density analysis. (G) LFq/HFq ratio at 105, 135, 165 and 195 days.
Data are mean ± SEM, n=10 ZL, 10 ZF, and 10 ZDF rats. P values of 0.05 and less were
considered statistically significant (Continued).
3.7 Discussion
HR was gradually reduced with age in ZDF, ZF and ZL rats. At 195 (6.5 months)
days of age HR was lowest in ZDF (265±8 BPM, n=10), compared to ZF (336±9 BPM,
n=10) and ZL (336±10 BPM, n=10). HR was 21% lower in ZDF compared to ZF and ZL
rats. Various factors may be responsible for the reduced HR in the ZDF rat including
changing physical activity, body temperature, autonomic drive, distribution of autonomic
receptors, circulating cardioactive factors and defects in the generation and propagation of
electrical activity within the heart. Physical activity and body temperature remained
relatively stable throughout the study so alterations in these parameters are unlikely to
explain the reduction in HR in ZDF compared to ZF and ZL rats. Analysis of the ECG
revealed a progressive age-dependent prolongation of PQ and QRS intervals. At 105, 135,
165 and 195 days (3.5, 5.5 and 6.5 months) of age the QRS interval was significantly
prolonged in ZDF compared to ZF rats. Age-dependent prolongation of the PQ interval
and QRS complex may suggest prolongation of atrial depolarization and/or electrical

94

conduction through the atrioventricular node and prolongation of ventricular
depolarization, respectively. There was a progressive prolongation of QT and QTc interval
with age and at 195 days of age QTc was significantly prolonged in ZF compared to ZDF
rats. The QT interval reflects the total duration of ventricular depolarization and
repolarization and the QTc is the QT interval corrected for HR. Prolongation of QRS
interval, which reflects ventricular depolarization, might partly underlie the reduction in
HR seen in ZDF compared to ZF and ZL rats. The significant reduction in HR coupled
with prolongation of the PQ interval and QRS in ZDF rats compared to ZF and lean rats
could also point to obesity- and diabesity-induced defects in the heart of diabetic and obese
rats. Obesity and diabetes are risk factors for the development of major cardiovascular
events including arrhythmia, myocardial infarction, cardiogenic shock and HF.
HRV provides a measure of sympathovagal modulation of the heart and alterations
of HRV might be partly attributed to disturbed autonomic control of the heart (Fazan et
al., 1997; Lo Giudice et al., 2002). HRV was lowest in ZDF, intermediate in ZF and
highest in ZL rats. PSD analysis showed that HRV at LFq was generally increased in ZDF
compared to ZF and ZL rats and HRV HFq was generally decreased in ZDF compared to
ZF and ZL rats. The LFq and HFq ranges in rodents do not have standard definitions
(Aubert et al., 1999; Cerutti et al., 1991; De Maria et al., 2019; Kuwahara et al., 1994;
Rowan et al., 2007). The HFq component is commonly recognized as a marker of
parasympathetic control (Aubert et al., 1999; Cerutti et al., 1991) and the LFq component
seems to be a complex mix of sympathetic and vagal effects (Bootsma et al., 1994). In this
study, the LFq and HFq ranges were set by inspection of the PSD and in agreement with
previous studies (F. C. Howarth et al., 2005). HR increases during inhalation and decreases
during exhalation, as defined by the respiratory sinus arrhythmia, which gives rise to a
spectral peak in the HRV PSD (Al-Ani et al., 1996). As such, the very low spectral power
and power associated with respiration were avoided in setting the LFq and HFq ranges.
The power spectral LFq/HFq ratio, which is used to assess sympathovagal balance (Chiou
& Zipes, 1998), was progressively increased with age in ZDF compared to ZF and ZL rats.
In the clinical setting reductions in the power of HR fluctuations at all frequencies have
been reported in diabetic patients as compared to controls indicating depression of both
parasympathetic and sympathetic activity (Lishner et al., 1987). In the current experiments
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there were progressive increases in LFq (sympathetic) between ZDF, ZF and ZL rats and
progressive decreases in HFq (parasympathetic) in ZDF compared to ZF and ZL rats.
These findings of increases in sympathetic, decreases in parasympathetic and increases in
LFq/HFq ratio might be expected to increase HR. Previous studies have reported reduced
expression of adrenoceptors in the ZDF heart (Haley et al., 2015; Thaung et al., 2015).
Presynaptic alpha 2-adrenoceptors and muscarinic receptors that are linked to inhibition
of norepinephrine (NE) release during nerve stimulation are impaired in the STZ-induced
diabetic rat (Gando et al., 1993). Parasympathetic denervation and degeneration of
sympathetic nerves have been reported in the alloxan-induced diabetic rat (Tomlinson &
Yusof, 1983). In the Kob (spontaneously diabetic) rat there was a decreased HFq power,
but not LFq/HFq ratio. The response of HFq power to atropine remained intact whilst the
response of the LFq/HFq ratio to propranolol was diminished, indicating functionally
inhomogeneous damage to the cardiac autonomic nerves (Sanyal et al., 2002). All of these
physiological alterations of the functions of the heart may be due to DM and obesityinduced structural changes in the heart of ZDF and ZF rats compared to ZL rats, because
it has been reported that more than a third of people with DM have CVD.
Circulating cardioactive factors may also be involved in changed HR in ZDF rats
(Haley et al., 2015; Laughlin et al., 2008). Previous studies have reported age-dependent
changes in insulin, modest reductions in thyroid hormone (Nam et al., 2013), increased
NE (Marsh et al., 2007), reduced levels of glucagon and increases in serum leptin (Wang
et al., 2014). Simonds et al. (2014) demonstrated the association of weight gain, leptin
levels, HR and blood pressure in mice that were implanted with radiotelemetric blood
pressure devices. Feeding the mice with a high fat diet (HFD) caused a progressive
increase in body weight. After 4 weeks of HFD there was an increase in HR and after 12
weeks of HFD an increase in systolic and diastolic BP. At 20 weeks, mice were returned
to normal chow and there was a progressive reduction in body weight which was followed
by reductions in HR, diastolic and systolic BP (Simonds et al., 2014). In the current
experiments HR was reduced in ZDF compared to ZF and ZL rats. Circulating leptin is
taken up into the brain where it mainly acts to regulate food intake, appetitive behaviors,
and energy expenditure. Although leptin levels are generally elevated in the ZDF rat, ZF
and ZDF rats are LepR-deficient (Wang et al., 2014). In addition to its actions in the brain
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leptin has been suggested to control cardiac electrical properties through β-AR activation.
Lin et al. (2015) identified LepR in atrial, sinus node, and ventricular myocytes isolated
from rat heart in which they showed that leptin at low doses (0.1-30 μg/kg) decreased
resting HR whilst at high doses (150-300 μg/kg), leptin produced a biphasic effect
(decrease followed by increase) in HR. In the presence of propranolol, high-dose leptin
only decreased HR and occasionally caused sinus pauses and ventricular tachycardia. The
leptin-induced inhibition of resting HR was completely reversed by leptin antagonist.
Leptin additionally increased HR-corrected QT interval (QTc), while leptin antagonist did
not. These results support the hypothesis that in addition to an indirect pathway through
sympathetic tone, leptin can directly reduce HR and prolong QT interval through its
receptor independent of β-AR stimulation (Lin et al., 2015).
Intrinsic defects in the electrical conduction system of the heart might also be
involved in the changed HR in ZDF rats. Previous isolated perfused heart studies have
demonstrated a reduction in basal HR in the ZDF rat (Cook et al., 2019; Haley et al., 2015;
Thaung et al., 2015). Experiments in the authors laboratory have also demonstrated
reduced HR in ZDF (100±5 BPM, n=16) and ZF (135±15 BPM, n=12) compared to ZL
controls (176±11 BPM, n=11) in the isolated perfused spontaneously beating heart
(unpublished data). Reductions in HR have also been previously reported in various
experimental models of type 1 and type 2 diabetes (C. F. Howarth et al., 2007; F. C.
Howarth et al., 2005, 2008, 2009, 2018; X. Huang et al., 2017; Kondo et al., 2019; Mabe
& Hoover, 2011; Zhang et al., 2019).
Disturbances in the generation and propagation of SAN APs might underlie the
reductions in HR in the ZDF and ZF rat hearts. Previous studies have reported lengthened
sinoatrial conduction time, prolonged pacemaker cycle length and prolonged APD that
was associated with a reduction in HCN proteins including expression of HCN2 and HCN4
in STZ-induced diabetic rat (C. F. Howarth et al., 2007; X. Huang et al., 2017). A reduction
in SAN beating rate associated with a reduction in funny current density and capacitance
and expression of various HCN proteins including HCN4 and gap junction proteins
including Cx43 has also been reported in the STZ-induced diabetic rat (Zhang et al., 2019).
In the AKITA mouse model of diabetes, the acetylcholine-activated K+ current (IKACh)
was reduced providing evidence for impaired parasympathetic regulation of HR and SAN
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function (Krishnaswamy et al., 2015). In human studies autopsy nodal tissue from type 2
diabetic patients was characterized by diffuse interstitial fibrosis and chronic ischemic
lesions with central areas of the SAN being worst affected (Hostiuc et al., 2013). In the
STZ-induced mouse there was a reduction in HR associated with fibrosis, infiltration of
macrophages, increased production of reactive oxygen species and depressed HCN4 in
sinus node tissue (Kondo et al., 2019). Collectively, these studies suggest that structural
and functional defects may partly underlie the reduced HR that has been widely reported
in diabetic heart.
In short, the HR was reduced by normal aging and further reduced by diabesity in
the absence of changes in body temperature and physical activity. Reductions in HRV
linked with altered sympathovagal drive might partly underlie disturbed HR in the ZDF
rat.

3.8 Conclusions
• HR was reduced by ageing and further reduced by diabesity in the absence of changes
in body temperature and physical activity.
• Power spectral analysis showed no significant differences in HRV at low frequencies,
reduced HRV at high frequencies and increased sympathovagal balance in ZDF
compared to ZF and ZL rats.
• Reductions in HRV linked with altered sympathovagal drive might partly underlie
disturbed HR in the ZDF rat.
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Chapter 4: Investigating the electrical conduction system in isolated
perfused heart in the ZDF and ZF compared to ZL rats
4.1 Introduction
Every cell in our body derives its electrical properties from the lipid bilayer cellular
membrane which acts as a barrier. The cell membrane allows the movement of nonpolar
hydrophobic molecules such as ions (K+, Na+, Ca2+) between the intracellular and
extracellular compartments through ion channels and transporters. The electrical
difference between the exterior and interior is called the “transmembrane potential” or
voltage and is measured in volts (V). In general, the value of the RMP is different between
cell types. However, most cells maintain a negative RMP (i.e., the cell interior membrane
is negative compared to the extracellular surface). The usual RMP is in the millivolt range
(from -80 mV to -30 mV). Numerous cell types are described as excitable cells, such as
nerve and muscle cells. These cells can depolarize spontaneously or depolarize in response
to a stimuli which causes transient and rapid changes in their RMP, these changes are the
APs. For their work on the giant squid axon Hodgkin and Huxley were awarded the Nobel
Prize in Physiology or Medicine in 1963 (Hacker et al., 2009; Sherman-Gold et al., 2012).
Increased very low-density lipoprotein-triglyceride (VLDL-TG) secretion by the
liver in the ZF rat model for dyslipidemia is mainly due to the relative hyperactivity of the
sympathetic and/or hypo-activity of parasympathetic liver innervation (Bruinstroop et al.,
2015). Experiments have been carried out to investigate the involvement of the autonomic
nervous system through surgical denervation of sympathetic or parasympathetic liver
nerves in ZF rats. Their results show that the cutting of the sympathetic liver nerve reduces
the secretion of VLDL-TG in obese rats and reduces plasma TG concentrations after 6
weeks. On the other hand, parasympathetic denervation results in an increase in plasma
cholesterol concentration. E Bruinstroop et al. (2015) also examined whether the effect of
sympathetic or parasympathetic liver enlargement was independent of changes in humoral
factors or changes in body weight or food intake. These studies demonstrated that
sympathetic denervation improves the lipid profile of ZF rats, while parasympathetic
denervation increases total cholesterol levels (Bruinstroop et al., 2015).
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4.2 Hypothesis
• An intrinsic defect is responsible for changes in heart rhythm in the ZDF and ZF rats.

4.3 Aims and objectives
• To explore the effects of obesity and diabesity on the electrical conduction system in
the isolated perfused heart in the ZDF and ZF compared to the ZL rat.
• The purpose of these experiments was to investigate whether alterations in electrical
conduction could be observed after removing extrinsic influences including autonomic
innervation and cardioactive substances circulating in the blood.

4.4 Methods
4.4.1 Measurement of action potential in isolated perfused heart
After completion of the biotelemetry experiments hearts were mounted in
Langendorff mode and retrogradely perfused at a constant flow rate of 8 ml per g heart-1
min-1 at physiological temperature (36-37°C) with a normal Tyrode (NT) solution
containing: 1.8 mM CaCl2, 1 mM MgCl2, 5 mM KCl, 140 mM NaCl, 10 mM glucose, 5
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and adjusted to pH 7.4
with NaOH and uninterruptedly gassed with oxygen. Cardiac metabolic activity will be
altered when the heart is perfused using NT since there will no longer be cardiac protective
substances and as a result an acute adaptation in metabolic activity will be different for
different rats. A suction electrode was attached to the left ventricle of the heart as shown
in Figure 32. The suction electrode was used to measure surface APs in the isolated
perfused heart. The APs were recorded in spontaneously beating and paced (5 Hz, Grass
medical SD5 stimulator) hearts. Signals were collected at 1000/sec, amplified
(ADInstruments, ML136 Bioamp) and conveyed via a digitizer (ADInstruments, Powerlab
4/30) to a PC and displayed on a monitor. Data were analyzed with ADInstruments
labchart 7 pro software v 7.3.8 (ADInstruments, Australia).
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Figure 32: Suction electrode connected to the heart for action potential measurements. The
arrow shows the location of the suction electrode.
4.4.2 Measurement of electrocardiogram in isolated perfused heart
After AP measurements had been recorded, the suction electrode was removed, and
the ECG electrodes were connected and placed on the left ventricle and apex of the isolated
heart (Figure 33).
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Figure 33: Electrodes placed on the left ventricle and apex of the heart for ECG
measurements. The arrows show the location of the ECG electrodes.
4.5 Statistics
Results were reported as the mean ± SEM of ‘n’ observations. The statistical
comparisons were done with IBM SPSS and Origin 9.0 (OriginLab, Northampton,
Massachusetts, USA) statistics software using either the independent samples t-test or oneway ANOVA and then by Bonferroni corrected t-tests for multiple comparisons, as
applicable. P values of 0.05 and less were considered statistically significant.
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4.6 Results
4.6.1 Action potential in isolated perfused heart
Typical records of AP in isolated perfused heart from ZL, ZF and ZDF rats are
shown in Figure 34A-C. The mean HR in spontaneously beating heart and paced (5 Hz)
heart is shown in Figure 34D. ZDF rats had the slowest heartbeat compared to the ZF and
ZL rats, however, the difference in HR was not statistically (p>0.05) significant (Figure
34D). Time to peak (TPK) AP was significantly higher in the ZF (9.68±1.76 msec, n=1213) compared to ZL (5.05±0.67 msec, n=10) but not compared to ZDF (7.47±0.67 msec,
n=16) in the spontaneously beating heart (Figure 34E). The APD (50% recovery) (Figure
34F) and APD (70% recovery) (Figure 34G) showed no significant differences between
groups. AMP of AP also showed no significant differences between groups (Figure 34H).

103

(A)

Figure 34: Ex-vivo action potential results. (A) Typical records of action potential from
ZL rat 5 and 1 sec expanded scale.
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(B)

Figure 34: Ex-vivo action potential results. (B) Typical records of action potential from
ZF rat at 5 and 1 sec expanded scale (Continued).
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(C)

Figure 34: Ex-vivo action potential results. (C) Typical records of action potential from
ZDF rat at 5 and 1 sec expanded scale (Continued).
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(D)

(E)

Figure 34: Ex-vivo action potential results. (D) Mean heart rate calculated from APDs and
(E) time to peak of action potential (Continued).
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(F)

(G)

Figure 34: Ex-vivo action potential results. (F) Action potential duration (50% recovery)
and (G) action potential duration (70% recovery) (Continued).
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(H)

Figure 34: Ex-vivo action potential results. (H) Amplitude of action potential. Data are
mean ± SEM. n=10 ZL, 12-13 ZF and 16 ZDF hearts. P values of 0.05 and less were
considered statistically significant (Continued).
4.6.2 Electrocardiogram in isolated perfused heart
Typical records of ECG in isolated perfused heart from ZL, ZF and ZDF rats at 5
and 1 sec intervals are shown in Figure 35A-C. The mean spontaneous HRs were
significantly (p<0.05) different. HR was lowest in the ZDF (99.55±5.39 BPM, n=16),
intermediate in ZF (135.02±14.87 BPM, n=11-12) and highest in ZL (176.06±11.02 BPM,
n=11) rats (Figure 35D). The QRS intervals on the other hand did not show any significant
differences (p>0.05) between the groups (Figure 35E).
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(A)

Figure 35: Ex-vivo ECG results. (A) Typical records of ECG from ZL rat 5 and 1 sec.
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(B)

Figure 35: Ex-vivo ECG results. (B) Typical records of ECG from ZF rat 5 and 1 sec
(Continued).

111

C

Figure 35: Ex-vivo ECG results. (C) Typical records of ECG from ZDF rat 5 and 1 sec
(Continued).
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(D)

(E)

Figure 35: Ex-vivo ECG results. (D) Heart rate from ECG and (E) QRS interval. Data are
mean ± SEM. n=11 ZL, 11-12 ZF and 16 ZDF hearts. P values of 0.05 and less were
considered statistically significant (Continued).
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4.7 Discussion
4.7.1 Action potential in isolated perfused heart
In the biotelemetry experiments, the heart was in-vivo hence, the heart was still
regulated by the ANS and circulatory cardioactive substances. In the isolated perfused
heart, the heart is not regulated by the ANS or circulatory cardioactive substances. The
mean HR in spontaneously beating heart calculated from AP records revealed that the ZDF
group had the slowest heartbeat compared to the other groups. TPK of AP was
significantly prolonged in the ZF compared to ZL but not compared to ZDF in the
spontaneously beating heart. In a previous study in single ventricular myocytes using
voltage clamp, the maximal AP upstroke velocity and resting potential were similar in
control and STZ diabetic rats (Nygren et al., 2007). Another study reported that
monophasic APD at 90% repolarization of the left atrial myocardium in the aged (2 year
old) group was shorter than in the adult (7-8 months old) and middle-aged (13-15 months
old) groups suggesting age related changes (C. Huang et al., 2006). Both age and disease
related changes may affect the AP measurements which was evident in this study.
4.7.2 Electrocardiogram in isolated perfused heart
Mean spontaneous HR in isolated perfused heart calculated from ECG records
revealed marked reductions in the ZDF compared to ZF and ZL groups similar to that of
the results from the biotelemetry study in section 3.6.3. The isolated heart QRS intervals
on the other hand did not indicate significant differences between groups unlike that seen
in the section 3.6.5.2 where the QRS complex showed some differences which has also
been reported in a large cohort study indicating that QRS duration was in fact influenced
by body mass index (Rao et al., 2021).
In the previous chapter, in-vivo experiments showed marked reductions in HR in
the presence of ANS. Similarly in this chapter, when the heart was isolated and no longer
regulated by ANS we also saw evidence of reduced HR from ECG readings. This suggests
an intrinsic defect may be responsible for changes in heart rhythm observed in obesity and
diabesity. Further studies will be required to investigate the changes happening within the
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heart muscles that might explain these rhythm disturbances. The following chapters will
investigate these changes.

4.8 Conclusions
• The mean HR in the spontaneously beating heart was slowest in ZDF rats, intermediate
in ZF and fastest in ZL controls.
• TPK AP was significantly prolonged in the ZF compared to ZL but not compared to
ZDF.
• Even in the absence of ANS control, ZDF heart rhythm was disturbed.
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Chapter 5: Investigating ventricular myocyte shortening using cell
imaging in the ZDF and ZF compared to ZL rats
5.1 Introduction
The effects of ventricular myocyte shortening has been widely investigated in
various models of diabetes. In a previous study STZ-induced diabetic rats showed lower
myocyte circumferential shortening compared to controls (Noda et al., 1993). One study
showed that the AMP of shortening was smaller and the rates of contraction and relaxation
were lower in myocytes from STZ compared to control rats (Choi et al., 2002). Another
study showed that the time course of shortening was prolonged to comparable amounts in
endocardial and epicardial regions of myocytes from STZ compared to control rats (Smail
et al., 2016). The time course of shortening was also prolonged in epicardial myocytes
from Goto-Kakizaki (GK) rats which are considered to be an experimental model of type
2 diabetes compared to epicardial controls (Smail et al., 2018). Furthermore, cell
shortening in db/db mice was found to be slowed in diabetic myocytes compared to
controls (Pereira et al., 2006).

5.2 Hypothesis
• Ventricular myocyte shortening is altered in ZDF and ZF rats.

5.3 Aims and objectives
• To investigate the effects of obesity and diabesity on the resting cell length (RCL),
TPK shortening, time to half (THALF) relaxation of shortening and AMP of shortening
in ventricular myocytes from ZDF, ZF compared to ZL rats.

5.4 Methods
Left ventricular myocytes were isolated from rat heart according to previously
described techniques (F. C. Howarth et al., 2020). Hearts were mounted on a modified
Langendorf perfusion system as shown in Figure 36.
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Figure 36: Cell isolation apparatus. The upper panel shows the cell isolation apparatus.
The lower panel shows a close-up of the canulated heart. (A) The lettering in the
photograph shows Ca2+-containing isolation solution, (B) Ca2+-free EGTA isolation
solution, (C) protease/collagenase isolation solution, (D) Langendroff apparatus, (E) water
bath and (F) peristaltic pump.
In short, the rats were euthanized utilizing a guillotine and hearts swiftly separated
and mounted for retrograde perfusion corresponding to the Langendorff method. Initially,
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hearts were perfused and maintained at a regular flow of 8 ml g heart-1 min-1 (36–37°C)
with cell dissociation solution comprising in mmol/l: 1.4 MgCl2, 5.4 KCl, 130 NaCl, 0.4
NaH2PO4, 0.75 CaCl2, 10 glucose, 5.0 HEPES, 10 creatine, and 20 taurine (pH 7.3).
Perfusion flow rate was modified to permit for variations in heart weight among animals.
After heart stabilization perfusion was switched for 4 min to Ca2+-free cell dissociation
solution containing 0.1 mmol/l EGTA, and then for 6 min with Ca2+-free cell dissociation
solution containing 0.05 mmol/l Ca2+, 0.075 mg/ml type XIV protease (Sigma,
Taufkirchen, Germany) and 0.75 mg/ml type 1 collagenase (Worthington Biochemical
Corp, NJ, USA). Left ventricle tissue was removed from the heart, shredded, and gently
agitated in collagenase-containing dissociation solution complemented with 1% bovine
serum albumin (BSA) for 4-5 min at 36-37°C. Cells were filtered using a 300 micron nylon
mesh (Cadisch Precision Meshes LTD, London, England). Tissue remaining in the nylon
mesh was then resuspended in more isolation solution supplemented with BSA. This
process was repeated 4 times. Cell filtrates were centrifuged and resuspended in cell
dissociation solution containing 0.75 mmol/l Ca2+. An example of isolated myocytes is
shown in Figure 37.

B

A

Figure 37: Rat myocytes original magnifications of 200X. (A) Rod shaped and (B) round
shaped. Adapted from (Sheu et al., 1984).
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After isolation, myocytes were allowed to settle by gravity on the bottom of a glass
Perspex chamber on the stage of an inverted Axiovert 35 microscope (Zeiss, Göttingen,
Germany). Ventricular myocyte shortening was measured according to previously
described techniques (F. C. Howarth et al., 2020). Typical records of shortening are shown
in Figure 38. Cells were perfused (3–5 ml/min) with NT comprising in mmol/l: 1.0 MgCl2,
140 NaCl, 1.8 CaCl2, 5 KCl, 5 HEPES, and 10 glucose (pH 7.4) at (35-36°C). Shortening
was measured in electrically stimulated (1 Hz) ventricular myocytes recorded with an
IonOptix MyoCam imaging system (IonOptix Corporation, Milton, MA, USA). RCL,
TPK shortening, THALF relaxation and AMP of shortening were measured. Data were
acquired and analyzed with IonWizard 6.6 version 10 software (IonOptix LLC, 396
University Ave. Westwood, MA 02090 USA).

Figure 38: Typical records of myocyte shortening and intracellular Ca2+. Top panel shows
shortening, second, third and fourth panels show measures of Fura-2. Second panel 340
nm, third panel 380 nm and fourth panel ratio of 340/380 nm. Fifth panel shows shortening
image analysis cursors in place at the ends of the myocyte.
A typical IonWizard shortening analysis is seen in Figure 39.
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Figure 39: Typical IonWizard shortening analysis from ZL rat. Upper panel shows a train
of shortening records. The middle panel shows the average of several records and the lower
panel shows typical analysis output.
5.5 Statistics
Results were reported as the mean ± SEM of ‘n’ observations. The statistical
comparisons were done by IBM SPSS and Origin 9.0 (OriginLab, Northampton,
Massachusetts, USA) statistics software using either the independent samples t-test or oneway ANOVA and then by Bonferroni corrected t-tests for multiple comparisons, as
applicable. P values of 0.05 and less were considered statistically significant.

5.6 Results
Typical records of myocyte shortening are shown in Figure 40A. The mean RCL
was significantly longer (p<0.05) in ZDF (117.93±0.99 µm) compared to ZL (112.58±1.42
µm) myocytes (40B). The mean TPK shortening was significantly prolonged (p<0.05) in
ZDF (158.59±3.05 msec) compared to ZF (130.33±2.57 msec) and ZL myocytes
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(126.54±3.09 msec) (40C). THALF relaxation of shortening (40D) and AMP shortening
(40E) were not significantly changed (p>0.05) in ZDF or ZF compared to ZL myocytes.

(A)

(B)

Figure 40: Electrically-evoked ventricular myocyte shortening. (A) Typical filtered
records of ventricular myocyte shortening in an electrically-stimulated cell and (B) resting
cell length.
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(C)

(D)

Figure 40: Electrically-evoked ventricular myocyte shortening. (C) Time to peak
shortening and (D) time to half relaxation of shortening (Continued).
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(E)

Figure 40: Electrically-evoked ventricular myocyte shortening. (E) Amplitude of
shortening. Data are mean ± SEM. n=79 ZL, 92 ZF and 87 ZDF cells from 13 ZL, 16 ZF
and 16 ZDF hearts. P values of 0.05 and less were considered statistically significant
(Continued).
5.7 Discussion
RCL was longer in ZDF compared to ZF and ZL myocytes which may indicate
hypertrophy in ZDF rat hearts. The force of contraction may be changed by either altering
the amount of free intracellular Ca2+, and/or by altering the sensitivity of the
myofilaments to Ca2+. Increasing the cell length of the myocyte increases the sensitivity
of TnC (a cardiac regulatory protein) to Ca2+ which is called “length-dependent Ca2+
sensitivity” and it can also lead to enhanced intracellular Ca2+ (Pinnell et al., 2007).
Evidence from the current study suggests that ZDF is not able to contract as efficiently
as ZL and ZF, perhaps due to reduced forced of contraction and/or ventricular dilatation
of myocytes (Obayashi et al., 2006; Pinnell et al., 2007). TPK shortening was prolonged
in ZDF compared to ZF and ZL myocytes which might partly be attributed to the
increased length of ZDF myocytes. It might also be attributed to alterations in Ca2+
transport as well as the velocity of contraction and relaxation (Mattiazzi et al., 1986).
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Neither THALF relaxation nor AMP shortening were significantly altered in ZDF or ZF
compared to ZL myocytes. Preserved THALF relaxation and AMP of shortening has been
previously reported in ZDF myocytes compared to ZL myocytes from rats aged 30-34
weeks of age (F. C. Howarth et al., 2012). In another study, AMP of shortening at 6 and
22 weeks were unchanged and the time course of shortening at 6 weeks was also
unaffected. However, the TPK shortening and THALF relaxation of shortening were
prolonged in ZDF rats at 22 weeks (Fulop et al., 2007).

5.8 Conclusions
• Hypertrophy in the ZDF may be present as suggested by the mean RCL which was
significantly longer in ZDF compared to ZL myocytes.
• The mean TPK shortening was significantly prolonged in ZDF compared to ZF and
ZL myocytes.
• THALF relaxation of shortening and AMP shortening were well preserved in ZDF or
ZF compared to ZL myocytes.
• Defects in the uptake and release of SR Ca2+ might partially underlie the altered time
course of shortening in ventricular myocytes from ZDF rat.
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Chapter 6: Investigating ventricular myocyte Ca2+ transport using
fluorescence photometry techniques in the ZL, ZF and ZDF rats
6.1 Introduction
The effects of ventricular myocyte Ca2+ transport has been widely investigated in
various models of diabetes. A previous study showed that intracellular Ca2+ signaling was
defective in myocytes from STZ rats, and may contribute to cardiomyopathy, by showing
that the AMP of caffeine induced Ca2+ transients was lower in STZ compared to control
myocytes (Choi et al., 2002). The study also suggested defects in Ca2+ release from the SR
by showing that the rate of rise of intracellular Ca2+ was decreased and the TPK of
intracellular Ca2+ was prolonged in myocytes from STZ compared to control rats (Choi et
al., 2002). Another study on db/db diabetic mice showed that intracellular Ca2+ transients
were decreased in isolated myocytes compared to controls as well as decreased SR Ca2+
transients which were measured by caffeine application (Pereira et al., 2006). Furthermore,
asymptomatic type 2 diabetic patients had slower SR Ca2+ release mainly due to decreased
expression of RyR in atrial myocardium compared to non-diabetic patients (Reuter et al.,
2008).

6.2 Hypothesis
• Alterations in Ca2+ signaling including SR Ca2+ transport might partly underlie defects
in ventricular myocyte shortening in ZDF and ZF rats.

6.3 Aims and objectives
• To investigate the effects of obesity and diabesity on resting Fura-2 ratio, TPK Ca2+
transient, THALF decay of the Ca2+ transient, and the AMP of Ca2+ transients in
ventricular myocytes from ZDF and ZF compared to ZL rats.
• To investigate the effects of obesity and diabesity on SR Ca2+ release and refilling in
ventricular myocytes from ZDF and ZF compared to ZL rats.
• To investigate the effects of obesity and diabesity on myofilament sensitivity to Ca2+
in ventricular myocytes from ZDF and ZF compared to ZL rats.
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6.4 Methods
6.4.1 Measurement of intracellular Ca2+ concentration
Intracellular Ca2+ concentration was assessed according to previously described
techniques (F. C. Howarth et al., 2020). Myocytes were loaded with the fluorescent
indicator Fura-2 AM (F-1221, Molecular Probes, OR, USA). In short, 6.25 µl of a 1.0
mmol/l stock solution of Fura-2 AM (dissolved in dimethylsulphoxide DMSO) was added
to 2.5 ml of cell suspension to give a Fura-2 concentration of 2.5 µmol/l. Myocytes were
gently shaken for 10 min at room temperature (24°C). Following loading, myocytes were
centrifuged, rinsed with NT to remove extracellular Fura-2 and kept for 30 minutes to
allow full hydrolysis of the intracellular Fura-2 ester. To determine intracellular Ca2+
concentration myocytes were interchangeably illuminated by 340 and 380 nm light
utilizing a monochromator (Cairn Research, Faversham, UK) which switched the
excitation light every 2 msec. The subsequent fluorescence emitted at 510 nm was
collected by a photomultiplier tube and the ratio of the emitted fluorescence at the two
excitation wavelengths (340/380 ratio) was analyzed to give an index of intracellular Ca2+
concentration. Resting Fura-2 ratio, TPK Ca2+ transient, THALF decay of the Ca2+
transient, and the AMP of Ca2+ transients were measured in electrically stimulated (1 Hz)
ventricular myocytes maintained at 35–36°C. The system used to measure intracellular
Ca2+ is shown in Figure 41. Typical records of 340 nm and 380 nm and 340/380 nm Fura2 signals are shown in Figure 42.
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Figure 41: Fluorescence photometry system. (A) Personal Computer, (B) electric
stimulator, (C) temperature controller, (D) Cairn fluorescence photometer control system,
(E) Ionoptix power supply, (F) inverted light microscope, (G) antivibration table, (H)
Ionoptix camera, (I) Faraday cage for noise insulation, (J) solution exchange power
supply, (K) waste, (L) monochromator and (M) light source.
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Data were acquired and analyzed with IonWizard 6.6 version 10 software (IonOptix
LLC, 396 University Ave. Westwood, MA 02090 USA). A typical example of the analysis
is shown in Figure 42.

Figure 42: Typical IonWizard SR Ca2+ analysis from ZL rat. The top panel shows
electrically-evoked and caffeine-evoked Ca2+ transients. The bottom panel shows typical
analysis output.
6.4.2 Measurement of sarcoplasmic reticulum Ca2+ transport
SR Ca2+ release was evaluated using previously described techniques (F. C.
Howarth et al., 2020). After achieving steady state Ca2+ transients in electrically stimulated
(1 Hz) myocytes maintained at 35–36°C and loaded with Fura-2, stimulation was stopped
for a period of 5 seconds. Caffeine (20 mM) was then applied for 10 seconds using a rapid
solution changing device (Levi et al., 1996). Electrical stimulation was then continued and
the Ca2+ transients were allowed to recover to steady state. Fractional release of SR Ca2+
was evaluated by comparing the AMP of the electrically-evoked steady state Ca2+
transients with that of the caffeine-evoked Ca2+ transient. Ca2+ refilling of SR was
evaluated by measuring the rate of recovery of electrically evoked Ca2+ transients
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following application of caffeine. Data were acquired and analyzed with IonWizard 6.6
version 10 software (IonOptix LLC, 396 University Ave. Westwood, MA 02090 USA).
6.4.3 Measurement of myofilament sensitivity to Ca2+
Ventricular myocyte shortening and intracellular Ca2+ were simultaneously
measured in Fura-2 AM loaded myocytes. Ventricular myocyte shortening and
intracellular Ca2+ were measured according to previously described techniques and
described on page 102 in the previous chapter (F. C. Howarth et al., 2020).
Myofilament sensitivity was measured according to previously described
techniques (Smail et al., 2018) as shown in FigureA & B. The Fura-2 ratio was plotted
against shortening. Myofilament sensitivity to Ca2+ was evaluated from the resulting
phase–plane diagram by measuring the gradient of the Fura-2 cell length trajectory during
late relaxation (500-800 msec) of the twitch contraction as previously described (F. C.
Howarth et al., 2011, 2012). The position of the trajectory reflects the relative myofilament
response to Ca2+ and therefore can be used as a measure of myofilament sensitivity to Ca2+
(Spurgeon et al., 1992).

6.5 Statistics
Results were reported as the mean ± SEM of ‘n’ observations. The statistical
comparisons were done by IBM SPSS and Origin 9.0 (OriginLab, Northampton,
Massachusetts, USA) statistics software using either the independent samples t-test or oneway ANOVA and then by Bonferroni corrected t-tests for multiple comparisons, as
applicable. P values of 0.05 and less were considered statistically significant.

6.6 Results
6.6.1 Ventricular myocyte intracellular Ca2+ concentration and sarcoplasmic reticulum
Ca2+ transport results
The experimental protocol to investigate intracellular Ca2+ is shown in Figure 43A.
Typical records of electrically-evoked Ca2+ transients are shown in Figure 43B. The mean
resting Fura-2 ratio (340/380 nm) was significantly increased (p<0.05) in ZF (0.47±0.007
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RU) compared to ZL (0.44±0.006 RU) myocytes (Figure 43C). The mean TPK Ca2+
transient was significantly prolonged (p<0.05) in ZF (67.26±5.69 msec) compared to ZL
(51.54±2.32 msec) myocytes (Figure 43D). THALF decay of the Ca2+ transient was
significantly prolonged (p<0.05) in ZDF (155.35±2.92 msec) compared to ZF
(131.11±3.26 msec) and ZL (129.17±3.12 msec) myocytes (Figure 43E). AMP of the Ca2+
transient was significantly increased (p<0.05) in ZF (0.118±0.007 RU) compared to ZDF
(0.094±0.004 RU) myocytes (Figure 43F).
TPK of caffeine-evoked Ca2+ transients was significantly prolonged (p<0.05) in
ZDF (575.46±30.96 msec) compared to ZF (468.81±29.73 msec) and in ZDF compared
to ZL myocytes (377.82±29.41 msec) (Figure 43G). THALF decay of the caffeine-evoked
Ca2+ transient was also significantly prolonged (p<0.05) in ZDF (2050.71±76.1 msec)
compared to ZF (1638.03±75.2 msec) and in ZDF compared to ZL myocytes (1459.4±60.6
msec) (Figure 43H). AMP of the caffeine-evoked Ca2+ transient was not significantly
changed (p>0.05) in ZDF or ZF compared to ZL myocytes (Figure 43I). Fractional release
of Ca2+ (Figure 43J) and recovery of the Ca2+ transients (Figure 43K) were significantly
lower in the ZDF compared to ZF myocytes.

(A)
Figure 43: Electrically-evoked Ca2+ transients and caffeine-evoked Ca2+ transient. (A)
Typical recording to illustrate the experimental protocol in a ventricular myocyte from a
ZL rat.
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(B)

(C)

Figure 43: Electrically-evoked Ca2+ transients and caffeine-evoked Ca2+ transient. (B)
Typical filtered records of electrically-evoked Ca2+ transients and (C) resting Fura-2 ratio
(Continued).
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(D)

(E)

Figure 43: Electrically-evoked Ca2+ transients and caffeine-evoked Ca2+ transient. (D)
Time to peak Ca2+ transient and (E) time to half decay Ca2+ transient (Continued).
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(F)

(G)

Figure 43: Electrically-evoked Ca2+ transients and caffeine-evoked Ca2+ transient. (F)
Amplitude of the Ca2+ transient and (G) time to peak of caffeine-evoked Ca2+ transient
(Continued).
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(H)

(I)

Figure 43: Electrically-evoked Ca2+ transients and caffeine-evoked Ca2+ transient. (H)
Time to half decay of caffeine-evoked Ca2+ transients and (I) amplitude of caffeine-evoked
Ca2+ transient (Continued).
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(J)

(K)

Figure 43: Electrically-evoked Ca2+ transients and caffeine-evoked Ca2+ transient. (J)
Fractional release of Ca2+ and (K) recovery of Ca2+ transient. Data are mean ± SEM. n=72
ZL, 70 ZF, 82 ZDF cells from 13 ZL, 16 ZF and 16 ZDF hearts. P values of 0.05 and less
were considered statistically significant. ES - Electrical stimulation, Caff - Caffeine
stimulation (Continued).
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6.6.2 Myofilament sensitivity to Ca2+ results
Typical records of electrically-evoked Fura-2 loaded myocyte shortening are
shown in (Figure 44A, upper panel). The mean RCL was not significantly altered in ZDF
(110.50±1.75 µm) or in ZF (107.04±1.96 µm) compared to ZL (107.33±1.66 µm) (Figure
44C). The mean TPK shortening was also not altered in ZDF (138.31±4.56 msec) or in ZF
(138.77±3.33 msec) compared to ZL myocytes (144.84±4.13 msec) (Figure 44D). The
THALF relaxation of shortening was also not altered (Figure 44E). However, the AMP
shortening (Figure 44F) was significantly increased (p<0.05) in ZF (6.38±0.41% RCL)
compared to ZL (5.13±0.35% RCL) but not compared to ZDF (5.60±3.33% RCL)
myocytes.
Typical records of electrically-evoked Ca2+ transients are shown in (Figure 44A,
lower panel). The mean resting Fura-2 ratio (340/380 nm) was significantly increased
(p<0.05) in ZDF (0.35±0.008 RU) compared to ZL (0.31±0.007 RU) myocytes (Figure
44G). The mean TPK Ca2+ transient was not significantly different (p>0.05) between ZF
(70.86±1.42 msec), ZDF (69.69±1.92 msec) and ZL (72.42±1.84 msec) myocytes (Figure
44H). THALF decay of the Ca2+ transient was significantly prolonged (p<0.05) in ZDF
(123.23±2.68 msec) compared to ZL (112.54±3.46 msec) and shortened in ZF
(106.08±2.30 msec) compared to ZL (112.54±3.46 msec) myocytes (Figure 44I). AMP of
the Ca2+ transient was not significantly different (p>0.05) between ZF (0.034±0.0013 RU),
ZDF (0.035±0.0017 RU) and ZL (0.037±0.0016 RU) myocytes (Figure 44J).
Electrically-evoked myocyte shortening and intracellular Ca2+ were recorded
simultaneously and a typical record in a ZL control myocyte is shown in (Figure 44A). A
typical phase-plane diagram of Fura-2 ratio versus cell length in a ZL control is shown in
(Figure 44B). The mean gradients of the Fura-2 cell length trajectory measured during the
late relaxation period of the twitch contraction (500–800 msec) are shown in (Figure 44K).
Results were not significantly changed in ZDF and ZF compared to ZL myocytes.
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(A)

(B)
Figure 44: Simultaneous measurement of shortening and intracellular Ca2+ in electrically
stimulated (1 Hz) ventricular myocytes. (A) Typical simultaneous recording of shortening
and Ca2+ in a ventricular myocyte from a ZL rat and (B) typical phase plane diagram of
Fura-2 ratio versus cell length and the arrow shows the area that the gradient was
measured.
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(C)

(D)

Figure 44: Simultaneous measurement of shortening and intracellular Ca2+ in electrically
stimulated (1 Hz) ventricular myocytes. (C) Resting cell length and (D) time to peak
shortening (Continued).
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(E)

(F)

Figure 44: Simultaneous measurement of shortening and intracellular Ca2+ in electrically
stimulated (1 Hz) ventricular myocytes. (E) Time to half relaxation of shortening and (F)
amplitude shortening (Continued).
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(G)

(H)

Figure 44: Simultaneous measurement of shortening and intracellular Ca2+ in electrically
stimulated (1 Hz) ventricular myocytes. (G) Resting Fura-2 ratio and (H) time to peak of
the Ca2+ transient (Continued).
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(I)

(J)

Figure 44: Simultaneous measurement of shortening and intracellular Ca2+ in electrically
stimulated (1 Hz) ventricular myocytes. (I) Time to half decay of the Ca2+ transient and
(J) amplitude of the Ca2+ transient (Continued).
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(K)

Figure 44: Simultaneous measurement of shortening and intracellular Ca2+ in electrically
stimulated (1 Hz) ventricular myocytes. (K) Mean gradient of the Fura-2 trajectory during
late relaxation of the twitch contraction during the period (500-800 msec). Data are mean
± SEM. Differences considered significant where p<0.05. n=57 ZL, 65 ZF and 52 ZDF
cells from 5 ZL, 5 ZF and 5 ZDF rats (Continued).
6.7 Discussion
6.7.1 Ventricular myocyte intracellular Ca2+ concentration
To investigate SR Ca2+ transport Fura-2 loaded myocytes were electrically
stimulated to generate Ca2+ transients and then, after a pause, were rapidly exposed to
caffeine to release Ca2+ from the SR. The resting Fura-2 ratio was higher in ZF compared
to ZL myocytes. Our study did not find any significant differences in cell capacitance
between ZDF, ZF and ZL myocytes. Further investigation of the molecular structure (see
chapter 9) specifically, the SR and the sarcomeres, which are important in ECC might
clarify the cause of the elevated Fura-2 ratio in ZF myocytes (Bers & Despa, 2013; Craig
et al., 2014; Lainé et al., 2018; Qadota & Benian, 2010; ter Keurs et al., 2008). The SR
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consists of longitudinal tubules, which release Ca2+ ions, and the terminal cisternae,
which are large regions in close proximity to the ends of the transverse tubules known as
“T-tubules”, that sequester and concentrate Ca2+. Evidence suggests that loss of T-tubule
integrity can profoundly affect ECC in myocytes (Ferrantini et al., 2014; Pavlović et al.,
2010; Silverthorn et al., 2007). It is important to note that T-tubule density can be
measured using whole-cell capacitance in voltage-clamped myocytes relative to cell area,
previous results indicate that rat myocytes can be kept in quiescent culture for 24 hours
with no detectable de-tubulation or loss of T-tubules (Pavlović et al., 2010). TPK Ca2+
transient was not changed in ZDF compared to ZL myocytes. However, TPK Ca2+
transient was prolonged in ZF compared to ZL myocytes. THALF decay of the Ca2+
transient was prolonged in ZDF compared to ZF and ZL myocytes. AMP of the Ca2+
transient was increased in ZF compared to ZDF myocytes. These disturbances in time
course of the Ca2+ transient might be partly attributed to defective SR Ca2+ transport.
TPK and THALF decay of the caffeine-evoked Ca2+ transients were prolonged in
ZDF compared to ZF and ZL myocytes as well as significantly lower fractional release
of Ca2+ and recovery of Ca2+ transients in the ZDF compared to ZF myocytes.
Collectively, these findings suggest delayed release and uptake of Ca2+ by the SR and
this in turn might be caused by defective SR Ca2+ release channel RyR and/or SERCA
pump activity (Currie & Smith, 1999; Fredersdorf et al., 2012; Obayashi et al., 2006;
Yaras et al., 2005). Previous studies in different experimental models of diabetes have
variously reported enhanced diastolic SR Ca2+ leakage, lower caffeine-evoked Ca2+
release and decreased rate of SERCA-mediated Ca2+ uptake in myocytes from db/db
diabetic mice (Belke et al., 2004; Stølen et al., 2009), as well as lowered AMP of caffeinereleasable Ca2+, SR store and rates of Ca2+ release and depressed re-sequestration into SR
in myocytes from STZ-induced diabetic rats (Shao et al., 2007). Reduced release of Ca2+
may be linked to structural defects in the SR Ca2+ release channel, and lowered levels of
expression of mRNA and protein for the Ca2+ release channel have been described in type
2 diabetic patients, db/db mice, STZ and alloxan-induced diabetic rats (Choi et al., 2002;
Pereira et al., 2006; Reuter et al., 2008; Zhou et al., 2006).
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6.7.2 Myofilament sensitivity to Ca2+
The Fura-2 cell length trajectory during the late stages of relaxation of the twitch
contraction was not significantly different in myocytes between groups, which indicates
that myofilament sensitivity to Ca2+ is not altered. Myofilament activation is modulated by
protein phosphorylation and myofilament proteins are substrates for PKC, PKA and
Ca2+/Calmodulin Dependent Protein Kinase II (CAMK) which in turn can induce changes
in myofilament sensitivity to Ca2+ (Solaro & Rarick, 1998). We have investigated certain
proteins that might affect myofilament sensitivity to Ca2+ and although no changes have
been found in Fura-2 length trajectory, we have found changes in expression of proteins
of TnC, Troponin I (TnI) and Troponin T (TnT) proteins between groups which may have
a bearing on myofilament sensitivity to Ca2+. Our previously published paper reported that,
diabetic GK rat Fura-2 cell length trajectory was steeper in GK compared to control
myocytes which suggested an increase in myofilament sensitivity to Ca2+ (F. C. Howarth
& Qureshi, 2008).
It is important to note that when shortening was measured without Fura-2, the mean
RCL was significantly longer in ZDF compared to ZL myocytes and the mean TPK
shortening was significantly prolonged in ZDF compared to ZF and ZL myocytes. In the
Fura-2 loaded cells in the myofilament study there was no significant changes in mean
RCL and mean TPK but increased AMP of shortening in the ZF group. The mean resting
Fura-2 ratio and mean TPK was higher in the ZF compared to ZL in the stand-alone study
while in the myofilament sensitivity study mean resting Fura-2 ratio was increased in the
ZDF compared to ZL and there was no significant difference in TPK Ca2+ transient.
THALF decay Ca2+ transient in the stand-alone study was significantly prolonged in ZDF
and ZF compared to ZL while in the myofilament sensitivity study it was prolonged in
ZDF and shortened in ZF compared to ZL. AMP Ca2+ transient was increased in the ZF
compared to ZDF in the stand-alone study while in the myofilament study there was no
significant differences between groups. These differences in the results between the two
sets of experiments could be due to experiments performed in cells from different batches
of animals, different batches of enzymes used for cell isolation producing different levels
of tissue digestion and different Fura-2 incubation times.
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6.8 Conclusions
• Although the AMP of shortening was generally well preserved in ZF and ZDF
myocytes, evidence of intracellular Ca2+ signaling defects were observed.
• Defects in the uptake and release of SR Ca2+ might partly underlie the altered time
course of the Ca2+ transient and shortening in myocytes from ZF and ZDF rat.
• Myofilament sensitivity to Ca2+ was generally well preserved.
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Chapter 7: Investigating the effects of Isoprenaline on ventricular
myocyte shortening and Ca2+ transport using cell imaging and
fluorescence photometry techniques in ZDF and ZF compared to ZL
rats
7.1 Introduction
Isoprenaline (ISO) is a β-sympathomimetic that stimulates the heart through its
actions on the β-ARs (National Center for Biotechnology Information, 2022). β-AR
dysregulation and associated cardiac dysfunction have been reported in ZDF rat heart
(Thaung et al., 2015). It was also reported that the β1-adrenergic receptor was the main
subtype of β-AR involved in cardiac dysfunction while β2-adrenergic receptor had indirect
effects (Cook et al., 2019). We have previously reported that there is increased
sympathovagal balance in ZDF compared to ZF and ZL rats (Sultan et al., 2021). Changes
in cardiac Ca2+ signaling vary across different experimental models of obesity and diabetes
(Hamilton & Terentyev, 2018).
Impaired β-AR responsiveness causes cardiac abnormalities in patients with
T2DM. β1 and β2 -AR responsiveness of HR, contraction and relaxation in the diabetic
heart were investigated. In general, diabetic hearts showed lower basal HR (non-diabetic
216±17 beats min−1 versus diabetic 151±23 beats min−1, p<0.05) and Western blots
showed 41% higher phosphorylation levels of AMP-kinase (AMPK), a key regulator of
cardiac energy metabolism in diabetic hearts since β2-AR activation in the heart has been
linked to stimulation of metabolic kinases (Li et al., 2010). In summary, β1-adrenoceptors
are the main subtype that regulates HR, contraction and relaxation which in turn regulates
chronotropic, inotropic and lusitropic β-AR responses in the healthy heart and the T2DM
heart. Moreover, the β2-AR subtype indirectly supports the β1-AR functional response in
the diabetic heart (Cook et al., 2019).

7.2 Hypothesis
• Sympathetic stimulation of contractility in ventricular myocytes is impaired in ZDF
and ZF rats.
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7.3 Aims and objectives
• To investigate the effects of ISO on the RCL, TPK shortening, THALF relaxation of
shortening and AMP of shortening in ventricular myocytes from ZDF and ZF
compared to ZL rats.
• To investigate the effects of ISO on resting Fura-2, TPK, THALF and AMP of the Ca2+
transient in myocytes from ZDF and ZF compared to ZL rats.
• To investigate the effects of ISO on SR Ca2+ release and refilling in ventricular
myocytes from ZDF and ZF compared to ZL rats.

7.4 Methods
In order to select an appropriate concentration for shortening experiments
electrically-stimulated (1 Hz) ZL myocytes were exposed to different concentrations of
ISO (10-6, 10-7 and 10-8 M). Typical records of shortening in ISO 10-6 M are shown in
(Figure 45A), 10-7 M (Figure 45B) and 10-8 M (Figure 45C). The upper panels of each
graph show the effects of NT and NT+ISO on shortening and the lower panel shows an
expanded scale showing the effects of NT+ISO on shortening. Our results showed that
the best dose to use in the following experiments was 10-8 M since the other doses
produced arrhythmic activity.
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(A)

Figure 45: Typical records showing the effects of ISO (10-6, 10-7 and 10-8 M) on
electrically-evoked (1 Hz) shortening in ventricular myocytes from ZL rats. (A) Records
of shortening in ISO 10-6 M. Upper panels show records of shortening in NT and NT+ISO
and lower panels show expanded scales of shortening in NT+ISO.
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(B)

Figure 45: Typical records showing the effects of ISO (10-6, 10-7 and 10-8 M) on
electrically-evoked (1 Hz) shortening in ventricular myocytes from ZL rats. (B) 10-7 M.
Upper panels show records of shortening in NT and NT+ISO and lower panels show
expanded scales of shortening in NT+ISO (Continued).
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C

Figure 45: Typical records showing the effects of ISO (10-6, 10-7 and 10-8 M) on
electrically-evoked (1 Hz) shortening in ventricular myocytes from ZL rats. (C) 10-8 M.
Upper panels show records of shortening in NT and NT+ISO and lower panels show
expanded scales of shortening in NT+ISO (Continued).
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7.4.1 Measuring the effects of Isoprenaline on ventricular myocytes shortening
The technique was previously described in chapter 5. The effects of ISO on
electrically-evoked shortening in ventricular myocytes from ZL, ZF and ZDF rats. RCL,
TPK shortening, THALF relaxation and AMP of shortening were measured in electrically
stimulated (1 Hz) ventricular myocytes maintained at (35–36°C).
7.4.2 Measuring the effects of isoprenaline on ventricular myocyte intracellular Ca2+
results
The technique was described previously in chapter 6. The effects of ISO on
electrically-evoked Ca2+ transients in ventricular myocytes from ZL, ZF and ZDF rats
were also investigated. Resting Fura-2 ratio, TPK Ca2+ transient, THALF decay of the
Ca2+ transient, and the AMP of Ca2+ transients were measured in electrically stimulated (1
Hz) ventricular myocytes loaded with Fura-2 AM and maintained at (35–36°C).

7.5 Statistics
Results were reported as the mean ± SEM of ‘n’ observations. The statistical
comparisons were done by IBM SPSS and Origin 9.0 (OriginLab, Northampton,
Massachusetts, USA) statistics software using either the independent samples t-test or oneway ANOVA and then by Bonferroni corrected t-tests for multiple comparisons, as
applicable. P values of 0.05 and less were considered statistically significant.

7.6 Results
7.6.1 Effects of isoprenaline on ventricular myocyte shortening
The effects of ISO on electrically-evoked shortening in ventricular myocytes from
ZDF and ZF compared to ZL control rats was investigated. Typical records of myocyte
shortening are shown in (Figure 46A). The mean RCL was not significantly different
between (p>0.05) ZDF, ZF and ZL myocytes (Figure 46B). Mean TPK shortening (Figure
46C) and THALF relaxation of shortening (Figure 46D) were also not significantly
different (p<0.05) between groups. In ISO stimulated myocytes the AMP of shortening
was significantly lower (p<0.05) in ZDF (8.75±0.57% RCL) and ZF (8.47±0.47% RCL)
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compared to ZL (10.43±0.53% RCL) myocytes (Figure 46E). During NT washout the
AMP of shortening returned to basal levels. Intracellular Ca2+ signaling is fundamental to
the process of myocyte shortening so further experiments were performed to investigate if
ISO induced changes in intracellular Ca2+ might partly underlie the changes in myocytes
shortening in ZDF and ZF compared to ZL myocytes.

(A)

Figure 46: Effects of ISO on electrically-evoked shortening in ventricular myocytes from
ZDF and ZF compared to ZL control rats. (A) Typical records.
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(B)

(C)

Figure 46: Effects of ISO on electrically-evoked shortening in ventricular myocytes from
ZDF and ZF compared to ZL control rats. (B) Resting cell length and (C) time to peak
shortening (Continued).
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(D)

(E)

Figure 46: Effects of ISO on electrically-evoked shortening in ventricular myocytes from
ZDF and ZF compared to ZL control rats. (D) Time to half relaxation of shortening and
(E) amplitude of shortening. Data are mean ± SEM. n=33 ZL, 27 ZF and 28 ZDF cells
from 7 ZL, 6 ZF and 8 ZDF rats. P values of 0.05 and less were considered statistically
significant (Continued).
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7.6.2 Effects of isoprenaline on ventricular myocyte intracellular Ca2+ results
The effects of ISO on electrically-evoked Ca2+ transients in ventricular myocytes
from ZDF and ZF compared to ZL control rats was investigated. Typical records of the
effects of ISO on electrically-evoked Ca2+ transient are shown in Figure 47A. The mean
resting Fura-2 ratio (340/380 nm) was not significantly different (p>0.05) between groups
(Figure 47B). The mean TPK Ca2+ transient was significantly shorter (p<0.05) in ZF
(305.63±7.46 msec) compared to ZL (328.7±6.66 msec) myocytes. During ISO
stimulation the TPK Ca2+ transient was also significantly shorter (p<0.05) in ZF
(322.05±7.2 msec) compared to ZL (354.7±7.12 msec) myocytes (Figure 47C). During
application of ISO the THALF decay of the Ca2+ transient was significantly prolonged
(p<0.05) in ZDF (104.64±4.39 msec) compared to ZL (81.7±6.15 msec) myocytes (Figure
47D). During NT the AMP of the Ca2+ transient was significantly lower (p<0.05) in ZF
(0.047±0.003 RU) compared to ZL (0.056±0.003 RU) myocytes. During ISO application,
the AMP of the Ca2+ transient was also significantly lower in ZF (0.061±0.005 RU)
compared to ZL (0.073±0.004 RU) myocytes (Figure 47E).

(A)

Figure 47: Effects of ISO on electrically-evoked Ca2+ transients in ventricular myocytes
from ZDF and ZF compared to ZL control rats. (A) Typical records.
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(B)

(C)

Figure 47: Effects of ISO on electrically-evoked Ca2+ transients in ventricular myocytes
from ZDF and ZF compared to ZL control rats. (B) Resting Fura-2 ratio and (C) time to
peak Ca2+ transient (Continued).
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(D)

(E)

Figure 47: Effects of ISO on electrically-evoked Ca2+ transients in ventricular myocytes
from ZDF and ZF compared to ZL control rats. (D) Time to half relaxation of the Ca2+
transient and (E) amplitude of the Ca2+ transient. Data are mean ± SEM.). n=23 ZL, 19
ZF, 25 ZDF cells from 7 ZL, 6 ZF and 8 ZDF rats. P values of 0.05 and less were
considered statistically significant (Continued).
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The effects of ISO on caffeine-evoked Ca2+ transients in ventricular myocytes from
ZDF and ZF compared to ZL rats was also investigated. Typical records of the effects of
ISO in electrically-evoked and caffeine-evoked Ca2+ transients in a ventricular myocyte
from a ZL rat are shown in Figure 48A. Typical records of caffeine-evoked Ca2+ transient
in a ventricular myocyte from a ZL rat are shown in an expanded scale in Figure 48B. TPK
caffeine-evoked Ca2+ transients were significantly prolonged (p<0.05) in ZF
(270.00±36.07 msec) compared to ZL myocytes (185.3±15.88 msec) and during ISO
application in ZF (284.36±3.78 msec) compared to ZL myocytes (188.81±18.55 msec)
(Figure 48C). THALF decay of the caffeine-evoked Ca2+ transient was not significantly
different (p>0.05) between groups (Figure 48D). AMP of ISO-stimulated Ca2+ transient
was significantly (p<0.05) decreased in ZF (0.05±0.006 RU) and ZDF (0.046±0.005 RU)
compared to ZL (0.063±0.005 RU) myocytes (Figure 48E). Fractional release of Ca2+
(Figure 48F) and recovery of the Ca2+ transients (Figure 48G) were not significantly
different between ZDF, ZF and ZL myocytes in NT or NT+ISO.

(A)

Figure 48: Effects of ISO on caffeine-evoked Ca2+ transients in ventricular myocytes from
ZDF, ZF and ZL control rats. (A) Typical records showing electrically-evoked and
caffeine-evoked Ca2+ transients in a ventricular myocyte from a ZL rat.
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(B)

(C)

Figure 48: Effects of ISO on caffeine-evoked Ca2+ transients in ventricular myocytes from
ZDF, ZF and ZL control rats. (B) Typical records showing caffeine-evoked Ca2+ transients
in ventricular myocytes from ZDF, ZF and ZL rat and (C) time to peak caffeine-evoked
Ca2+ transient (Continued).
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(D)

(E)

Figure 48: Effects of ISO on caffeine-evoked Ca2+ transients in ventricular myocytes from
ZDF, ZF and ZL control rats. (D) Time to half relaxation caffeine-evoked Ca2+ transient
and (E) amplitude of caffeine-evoked Ca2+ transients (Continued).
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(F)

(G)

Figure 48: Effects of ISO on caffeine-evoked Ca2+ transients in ventricular myocytes from
ZDF, ZF and ZL control rats. (F) Fractional release of Ca2+ and (G) recovery of Ca2+
transients. Data are mean ± SEM. n=20 ZL, 21 ZL ISO, 13 ZF, 14 ZF ISO, 15 ZDF, 15
ZDF ISO cells from 7 ZL, 6 ZF and 8 ZDF rats. P values of 0.05 and less were considered
statistically significant. ES - Electrical stimulation, Caff - Caffeine stimulation
(Continued).
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7.7 Discussion
7.7.1 Effects of isoprenaline on ventricular myocyte shortening
The mean RCL was not substantially different between ZDF, ZF and ZL myocytes.
Whilst the RCL data was not consistent with cardiac hypertrophy in ZF rat heart it must
be appreciated that cardiac myocyte volume is a product of cell length, width and
thickness. The mean TPK shortening as well as THALF relaxation of shortening were
not significantly different between ZF, ZDF and ZL myocytes. Preserved THALF
relaxation and AMP of shortening has been previously described in ZDF myocytes
compared to ZL myocytes from rats aged 30-34 weeks of age (F. C. Howarth et al., 2012).
In another study, AMP of shortening at 6 up to 22 weeks was unchanged and the time
course of shortening at 6 weeks was also unaffected. However, the TPK shortening and
THALF relaxation of shortening were increased in ZDF rats at 22 weeks (Fulop et al.,
2007). ISO application increased the AMP of shortening to a lesser extent in ZDF and
ZF compared to ZL myocytes suggesting that the β-adrenergic system and Ca2+ signaling
may be altered in ZF and ZDF rats. It was reported previously that abnormalities in
adrenal receptors in ZDF rat hearts were present at the molecular level where the
expression level of β1-adrenoceptors was downregulated whereas that of β2adrenoceptors was upregulated (Thaung et al., 2015).
7.7.2 Effects of isoprenaline on ventricular myocyte intracellular Ca2+
The mean resting Fura-2 ratio (340/380 nm) was not significantly different
between groups. The mean TPK Ca2+ transient was significantly lower in ZF compared
to ZL myocytes during NT or NT+ISO. Application of ISO prolonged THALF decay of
the Ca2+ transient in ZDF compared to ZL myocytes and continued even after washout.
The AMP of the Ca2+ transient was significantly lower in ZF compared to ZL myocytes
during NT and NT+ISO application and washout. The disturbances in time course of the
Ca2+ transient might be partly due to defective SR Ca2+ transport. To investigate SR Ca2+
transport Fura-2 loaded myocytes were electrically stimulated to generate Ca2+ transients
and then, after a pause, were rapidly exposed to caffeine to release Ca 2+ from the SR.
TPK of caffeine-evoked Ca2+ transients was significantly prolonged in ZF compared to
ZL myocytes during NT and NT+ISO application. On the other hand, THALF decay of
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the caffeine-evoked Ca2+ transient was not significantly different between ZF, ZDF and
ZL myocytes. During application of ISO the AMP of the caffeine-evoked Ca2+ transient
was smaller in ZDF and ZF compared to ZL myocytes. Reduction of caffeine-evoked SR
Ca2+ release might partly underlie the decreased effectiveness of ISO on myocyte
shortening in ZDF and ZF myocytes compared to ZL. Fractional release of Ca2+ during
NT or NT+ISO was not significantly altered in ZDF compared to ZF and ZL myocytes
suggesting that the fraction of SR Ca2+ mobilized during each stimulation was less in
ZDF compared to ZF and ZL myocytes. The rate of recovery of the Ca2+ transient
following NT or NT+ISO were not significantly different in ZDF and ZF compared to
ZL myocytes suggesting that the refilling of the SR after stimulation was similar in the
three groups. Collectively, these findings suggest delayed release of Ca2+ by the SR which
in turn may be ascribed to defects in the SR Ca2+ release channel (Belke et al., 2004;
Cagalinec et al., 2019; Maier et al., 2005). Previous studies in various experimental
models of diabetes have reported enhanced diastolic SR Ca2+ leakage, lower caffeineevoked Ca2+ release and decreased rate of SR Ca2+-ATPase-mediated Ca2+ uptake in
myocytes from db/db diabetic mice (Belke et al., 2004; Stølen et al., 2009), as well as
lowered AMP of caffeine-releasable Ca2+, SR store and rates of Ca2+ release and
depressed re-sequestration into SR in myocytes from STZ-induced diabetic rats (Shao et
al., 2007). Furthermore, ISO application was less effective in increasing the AMP of
shortening in ZDF and ZF compared to ZL suggesting a defect in the β-adrenergic system
as well as signs of either hypertrophy or dilatation in these groups (Cook et al., 2019;
Thaung et al., 2015). Another reason for lower AMP in these rats could be lower release
of SR Ca2+ which may be linked to structural defects in the SR Ca2+ release channel, and
lower levels of expression of mRNA and Ca2+ release channel protein which have been
previously reported in type 2 diabetic patients, db/db mice, STZ and alloxan-induced
diabetic rats (Choi et al., 2002; Pereira et al., 2006; Reuter et al., 2008; Zhou et al., 2006).

7.8 Conclusions
• ISO was less effective at generating an increase in AMP of shortening in ZDF and ZF
compared to ZL myocytes.
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• Defects in Ca2+ signaling in the ZDF and ZF were present suggesting that defective
SR Ca2+ transport might partly underlie these abnormalities.
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Chapter 8: Investigating L-type Ca2+ current and Na+/Ca2+ exchange
current in ventricular myocytes from ZDF and ZF compared to ZL rats
8.1 Introduction
During the process of excitation-contraction coupling the arrival of an AP
depolarizes the cardiac myocyte membrane, leading to the opening of L-type Ca2+
channels. There is a small entry of Ca2+ which triggers a large release of Ca2+ from the SR.
The rise of intracellular Ca2+ initiates and regulates the process of contraction (S. P.
Alexander, Mathie, et al., 2021; Catterall, 2011). Defects in ICal might alter SR Ca2+ release
and the generation of the Ca2+ transient.
Recovery of intracellular Ca2+ to resting levels is mainly driven by uptake of Ca2+
into the SR and extrusion of Ca2+ from the cell via the NCX, operating in forward mode.
Defects in NCX might contribute to alterations in the decay of the Ca2+ transient
(Armoundas et al., 2003; Ashrafi et al., 2016; Hamilton & Terentyev, 2018; Hattori et al.,
2000).

8.2 Hypothesis
• Alterations in L-type Ca2+ and NCX current may partly underlie defective contraction
in ZDF and ZF rats.

8.3 Aims and objectives
• To investigate the effects of obesity and diabesity on L-type Ca2+ current and NCX
current in ventricular myocytes from ZDF and ZF compared to ZL rats.

8.4 Methods
The patch-clamp technique allows the researcher to measure the potential (voltage)
differences in biological systems usually in millivolts (mV). It also allows the researcher
to measure the current (I) measured in (Amperes), which is the flow of ions or electrical
charge passing a point per unit of time. The usual current range is from Picoamperes (pA)

167

to Microamperes (µA) in biological systems. The ease of flow of current between two
points is called conductance (G), and it is measured in Siemens (S). Current (I) can flow
through conductors and resistors. Conductivity is an ion channel property, and it is usually
measured in the Picosiemens (pS) range in biological systems while resistance (R)
measured in Ohms (Ω) is the inverse of conductance (G). The total electrical conductivity
of a membrane is the sum of all ion channel single conductivities in parallel. This provides
one of the most important laws in electricity called “Ohms Law” (Hacker et al., 2009;
Sherman-Gold et al., 2012).

Ohms Law Equation 2:
G = I/R or G = I/(Vm-Es) or ΔV = IR
G = Conductance (S)
I = Current (A)
R = Resistance (Ω)
V = Voltage or potential (V)
Vm = membrane potential or command potential or test potential
Es = equilibrium potential or reverse potential
The second important equation in ion channel investigation informs us about the
equilibrium potential (Es) and it is also known as the “reversal potential”. It is the cell
membrane potential at which there is no net flow of ions through the membrane.
Equilibrium reflects the fact that the net ion flow, for the specific ion, at the given voltage
is zero (Hacker et al., 2009; Sherman-Gold et al., 2012).

Nernst Equation 3:
Es = (RT/ZsF) ln ([S]o/[S]i)
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R = the universal gas constant
T = the temperature in Kelvin
F = the Faraday constant
S = the particular ion type with charge Zs
[S]o = the ion concentration outside the cell membrane
[S]i = the intracellular ion concentration
A picture of the patch-clamp electrophysiology rig used in the experiments is shown in
Figure 49.
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Figure 49: Patch-clamp electrophysiology rig. (A) Personal Computer, (B) power supply
for microscope light, (C) amplifier, (D) digitizer, (E) chamber monitor, (F) manipulator
controls, (G) inverted light microscope, (H) Faraday cage for noise insulation, (I)
antivibration table, (J) waste line, (K) headstage, (L) micromanipulator, (M) reference
electrode, (N) waste line and (O) pipette holder.
8.4.1 Measurement of L-type Ca2+ current
ICaL was measured according to previously described techniques (F. C. Howarth et
al., 2020). ICaL was recorded with an Axopatch 200B amplifier (Molecular Devices,
Sunnyvale, CA, USA). The analog signal was filtered using a four-pole Bessel filter with
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a bandwidth of 2 kHz and digitized at a sampling rate of 10 kHz by software control
(pClamp 10.6.2.2, Molecular Devices, CA, USA). Patch pipettes were fabricated from
filamented TW150F-4 4 IN thin-wall borosilicate glass 1.5 OD/1.2 ID (World Precision
Instruments, FL, USA). The pipettes were made using a flaming/brown horizontal
micropipette puller (Sutter instruments CO., Model P-97) and then further air-heat
polished using a List Medical L/M CPZ 101 Fire coating polisher. The whole cell bath
solution comprised in mmol/l: 4 NaCl, 2 CaCl2, 1 MgCl2, 110 TEA-Cl, 4 CsCl, 10 HEPES
and 10 glucose (pH 7.4 with CsOH). The pipette solution comprised in mmol/l: 2 MgCl2,
2 MgATP, 10 TEA-Cl, 140 CsCl, 10 HEPES and 10 EGTA (pH 7.25 with CsOH).
Electrode resistances were 1-3 MΩ, and seal resistances were 1-5 GΩ. Experiments were
performed at room temperature (25-26°C). The current-voltage relationship was obtained
by applying 1000 msec long pulses to different voltages between -60 and +50 mV from a
holding potential of -50 mV. The inactivation was measured as the relationship of peak
current at a test pulse of 0 mV and the AMP of peak current during the 1000 msec long
pre-pulses. Recovery from inactivation was measured using a two-pulse protocol, in which
one 1000 msec pulse was compared with 50 msec depolarizing pulses from -50 to 0 mV
that were separated by inter-pulse intervals of different durations. The peak Ca2+ current
AMP measured during the second pulse was normalized to the current measured by the
first pulse and their ratio was plotted against the inter-pulse interval. Data were acquired
and analyzed with pClamp software v 10.6.2.2 (Molecular Devices, CA, USA).
One important aspect of voltage gated ion channels is their “open probability”
which is essentially the random opening and closing of the channel also referred to as
“gating”. The channels usually transition between three different conformational changes
which are active or open, inactive and closed or resting (Figure 50). The transition from
the open to the inactive is referred to as “inactivation” while the transition from the inactive
to the closed is referred to as “recovery from inactivation” (Hacker et al., 2009; Kornreich,
2007). In our study we have recorded the recovery from inactivation of the L-type Ca2+
channels.
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Figure 50: Markov model demonstrating the transition of an ion channel between its
opened, closed, and inactivated configurations. The asterisk represents a state that passes
current. Adapted from (Kornreich, 2007).
8.4.2 Measurement of Na+/Ca2+ exchange current
INCX was measured according to previously described techniques (F. C. Howarth et
al., 2014). INCX was recorded using a descending voltage ramp from +100 mV to −100 mV
from a holding potential of −40 mV for 2 s duration. INCX was measured as the current
sensitive to nickel (Ni2+), hence, Ni2+-insensitive components were subtracted from total
currents to isolate INCX. Membrane current was recorded with an Axopatch 200B amplifier
(Molecular Devices, Sunnyvale, CA, USA). The analog signal was filtered using a fourpole Bessel filter with a bandwidth of 2 kHz and digitized at a sampling rate of 10 kHz
under software control (pClamp 10.6.2.2, Molecular Devices, CA, USA). Patch pipettes
were fabricated from filamented 4 inch thin-wall borosilicate glass 1.5 OD/1.2 ID
(TW150F-4, World Precision Instruments, Inc., FL, USA). The pipettes were made using
a flaming/brown horizontal micropipette puller (Sutter Instruments Co., Model P-97) and
then further air-heat polished using a List Medical L/M CPZ 101 fire coating polisher. The
whole cell bath solution contained the following in mmol/l: 2 MgCl2, 2 CaCl2, 150 NaCl,
5 CsCl, 10 glucose and 10 HEPES (pH=7.4). Nifedipine (10 µM), Oubain (100 µM), and
Niflumic acid (30 µM) were used to block Ca2+, Na+- K+-ATPase, and Cl− currents,
respectively. 10 mM nickel chloride solution was used to block I NCX. K+ currents were
minimized by Cs+ substitution for K+ in both pipette and external solutions. The pipette
solution contained in mmol/l: 2 MgCl2, 20 NaCl2, 120 CsCl, 1 MgATP, 10
tetraethylammonium chloride (TEACl), 1 CaCl2, 10 HEPES and 10 1,2-bis (o-
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aminophenoxy) ethane-N,N,N’,N’-tetraacetic acid (BAPTA) (pH=7.2) with CsOH.
Electrode resistances were 1-3 MΩ, and seal resistances were 1-5 GΩ. Experiments were
performed at room temperature (25-26°C).

8.5 Statistics
Results were reported as the mean ± SEM of ‘n’ observations. Statistical
comparisons were done with IBM SPSS and Origin 9.0 (OriginLab, Northampton,
Massachusetts, USA) statistics software using either the independent samples t-test or oneway ANOVA then by Bonferroni corrected t-tests for multiple comparisons, as
appropriate. P values of 0.05 and less were considered statistically significant.

8.6 Results
8.6.1 L-type Ca2+ current
Typical records of ICaL activation and inactivation are shown in Figure 51A & B.
The current/voltage relationship (I-V curve) is shown in Figure 51C. There were no
significant differences (p>0.05) in the AMP of ICaL at test potentials in the range -60 to
+50 mV. L-type Ca2+ activation and inactivation currents are shown in Figure 51D. The
results indicate that the activation, inactivation and window current were not significantly
altered (p>0.05) in ZDF and ZF compared to ZL myocytes. The mean membrane
capacitance was not significantly different (p>0.05) between ZL (279.53±19.49 pF), ZF
(291.24±25.46 pF) and ZDF (263.29±13.45 pF) myocytes.
Typical records of ICaL after recovery from inactivation in a ventricular myocyte
from a ZL rat is shown in Figure 51E. Mean recovery from inactivation at various interpulse intervals is shown in Figure 51F. There were no significant differences (p>0.05)
between ZDF, ZF and ZL myocytes. The results are surprising considering the significant
changes in Ca2+ signaling and signs of hypertrophy. Under these circumstances changes
in current densities as well as changes in window current might be expected.
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(A)

Figure 51: L-type Ca2+ current. (A) Typical records of ICaL activation (upper panel)
together with voltage protocol (lower panel) in a ventricular myocyte from a ZL rat.
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(B)

Figure 51: L-type Ca2+ current. (B) Typical records of ICaL inactivation (upper panel) and
voltage protocol (lower panel) in a ventricular myocyte from a ZL rat (Continued).
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(C)

(D)

Figure 51: L-type Ca2+ current. (C) Graphs showing current-voltage relationship and (D)
activation, inactivation, and window current. Data are means ± SEM. n=17 ZL, 17 ZF and
14 ZDF cells from 3 ZL, 3 ZF and 3 ZDF rats (Continued).
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(E)

Figure 51: L-type Ca2+ current. (E) Typical records of recovery from inactivation at
various inter-pulse intervals (upper panel) and voltage protocol (lower panel) in a
ventricular myocyte from a ZL rat (Continued).
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(F)

Figure 51: L-type Ca2+ current. (F) Graph showing recovery from inactivation at various
inter-pulse intervals with variable duration. Data are means ± SEM. n=16 ZL, 17 ZF and
13 ZDF cells from 3 ZL, 3 ZF and 3 ZDF hearts. P values of 0.05 and less were considered
statistically significant (Continued).
8.6.2 Na+/Ca2+ exchange current results
The NCX is the main route by which Ca2+ is extruded from the cell facilitating
recovery of intracellular Ca2+ to basal levels (S. P. Alexander, Kelly, et al., 2021) therefore
experiments were performed to investigate INCX. Records of current in the absence (upper
panel) and presence of 10 mM Ni2+ (middle panel) in a myocyte from a ZL rat together
with the voltage protocol (lower panel) are shown in Figure 52A. Mean INCX density is
shown in Figure 52B. Mean current density at selected voltages is shown in Figure 52C.
There was no significant difference (p>0.05) in mean current density between ZDF, ZF
and ZL rats at test potentials of 40, 60 and 80 mV. The mean membrane capacitance was
not significantly (p>0.05) different between ZL (179.60±14.87 pF), ZF (213.50±15.87 pF)
and ZDF (167.92±18.01 pF) myocytes. INCX was not significantly altered (p>0.05) in ZDF
and ZF compared to ZL myocytes.
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(A)

Figure 52: Na+/Ca2+ exchange current. (A) Typical records of INCX in the absence of Ni
(upper panel), in the presence of Ni (middle panel) and voltage protocol (lower panel) in
a ventricular myocyte from a ZL rat (Continued).
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(B)

(C)

Figure 52: Na+/Ca2+ exchange current. (B) Mean INCX density and (C) mean current density
at selective voltages. Data are means ± SEM. n=10 ZL, 12 ZF and 13 ZDF cells from 7
ZL, 6 ZF and 8 ZDF hearts. P values of 0.05 and less were considered statistically
significant (Continued).
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8.7 Discussion
8.7.1 L-type Ca2+ current
Myocyte contraction is regulated by influx of Ca2+ via the L-type Ca2+ channels
which provides the trigger for SR Ca2+ release. Disturbances of ICaL would have
implications for the release of SR Ca2+. ICaL was not significantly changed in ZDF or ZF
compared to ZL myocytes over a wide range of test voltages. However, previous studies
performed in Zucker rats aged 9-13 and 30-34 weeks have demonstrated reduction in ICaL
over a range of test potentials in ZDF myocytes (F. C. Howarth et al., 2011, 2012).
Another study in ZF rats aged 16-17 weeks demonstrated a reduction in ICaL and defective
Ca2+ inactivation (Lin et al., 2012). ICaL activation, inactivation, and recovery from
inactivation were not significantly altered in myocytes from epicardial and endocardial
regions in STZ treated rats or Wistar controls (Smail et al., 2016) which was also evident
in the current Zucker study.
8.7.2 Na+/Ca2+ exchange current
Recovery of intracellular Ca2+ to resting levels is mainly driven by uptake of Ca2+
into the SR and extrusion of Ca2+ from the cell via the NCX, operating in forward mode.
Defects in NCX might contribute to alterations in the decay of the Ca2+ transient
(Armoundas et al., 2003; Ashrafi et al., 2016; Hamilton & Terentyev, 2018; Hattori et
al., 2000). In our study, INCX was not significantly changed in ZDF or ZF compared to
ZL myocytes suggesting that the prolonged decay of the Ca2+ transient could not be
attributed to defective INCX. Nevertheless, TPK and THALF decay of the caffeine-evoked
Ca2+ transients were prolonged in ZDF suggesting there may be defects in SR Ca 2+
release/uptake or NCX transport in ZDF myocytes (Armoundas et al., 2003; Ashrafi et
al., 2016; Hamilton & Terentyev, 2018; Hattori et al., 2000). These results are consistent
with a previous study by Lima-Leopoldo et al that showed no upregulation of NCX genes
in high-fat diet (obese) Wistar rats (Lima-Leopoldo et al., 2008). However, Hattori et al
(2000) showed that STZ-induced diabetic rats had diminished INCX density compared to
control and reduced NCX channel expression and function due to reduced NCX protein
and mRNA downregulation (Hattori et al., 2000).
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8.8 Conclusions
• Mean ICaL was not significantly altered in ZDF and ZF compared to ZL myocytes.
• Activation, inactivation and recovery of inactivation were not significantly altered in
ZDF and ZF compared to ZL myocytes.
• Mean INCX was also not significantly altered in ZDF and ZF compared to ZL myocytes.
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Chapter 9: Investigating the expression of proteins and structure of
ventricular muscle using Western blot and transmission electron
microscope techniques in the ZDF and ZF compared to ZL rats
9.1 Introduction
In T1DM, marked systolic dysfunction was linked with severe nitro-oxidative
stress, fibrosis, and apoptosis. These pathological characteristics were less notable or
absent, while hypertrophy of cardiomyocytes was comparable in T2DM, which was
associated with an unchanged systolic function and an increase in diastolic stiffness. In
addition to the pro-apoptotic caspase-12, the expression of mRNA of the hypertrophy
markers c-fos, c-jun, and β-MHC was increased in T1DM, but remained or was only
slightly increased in T2DM. Nonetheless, the expression of profibrotic TGF-β1 was
enhanced in T1DM and showed a reduction in T2DM (Radovits et al., 2015).
In ZDF ventricular myocytes, alterations in the time course of contraction and Ca2+
transients could be due to changing expression of genes encoding myosin heavy chain and
L-type Ca2+ channel proteins (F. C. Howarth et al., 2011). At the early stages of DM,
changes in the pattern of genes encoding cardiac muscle regulatory proteins, can offer
biomarkers that indicate the onset of heart muscle pathophysiology and chances for
restorative interventions in the heart of T2DM (F. C. Howarth et al., 2011).
The impact of ageing on cardiomyocyte function and development of T2DM in
ZDF rats has been investigated by (Fulop et al., 2007). They reported that an increase in
O-linked N-acetylglucosamine (O-GlcNAc) on speciﬁc proteins may contribute to
impaired cardiomyocyte function in diabetes and the elevated level of O-GlcNAc on
different proteins seems to be regulated differently depending on age and diabetes (Fulop
et al., 2007).
Recently, a new mediator of cardiac contractility has been reported (Daniels et al.,
2018), myocardial isoform of Ca2+/calmodulin-dependent protein kinase II-delta
(CaMKIIδ). It is a multifunctional serine/threonine protein kinase that regulates proteins
linked with cardiac Ca2+ flux, including RYR and L-type Ca2+ channels as well as proteins
essential to sarcomere cross bridge cycling and structure. CaMKIIδ plays an important
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role in cardiac contraction and relaxation. Constant activation of CaMKIIδ is associated
with some cardiac pathologies, including maladaptive hypertrophy, apoptosis, and
arrhythmias. It was found that CaMKIIδ activity is enhanced during hyperglycemia and
can alter intracellular Ca2+ management in cardiovascular cells, which ultimately leads to
reduced heart performance (Daniels et al., 2018). Daniels et al. (2018) investigated the
effects of CaMKIIδ on cardiac contractility in ZDF rats. Their results showed that
CaMKIIδ has an important role in modulating the performance of the diabetic heart,
suggesting a potential therapeutic role for CaMKII inhibitors in improving myocardial
function during T2DM (Daniels et al., 2018).
In isolated hearts of ZDF rats, the effect of modified substrate utilization on heart
function was studied to determine whether changes in cardiac metabolism in T2DM are
associated with contractile dysfunction or impaired response to ischemia. Hearts from
ZDF and ZL control rats were isolated and perfused with glucose, lactate, pyruvate, and
palmitate. The experiments indicated that the transition from carbohydrates to fatty acids
for oxidative energy production did not increase myocardial oxygen consumption and was
not linked with impaired response to ischemia and reperfusion (Wang et al., 2004).
The storage of fat in heart muscle was associated with a decrease in the production
of force, which has consequences for the heart to pump blood effectively and because the
accumulation of lipids in the heart muscle has been associated with HF. Fats in the blood
can be transferred to heart muscle cells, where they can be stored or used to generate
energy within the mitochondria, and with the help of transport proteins, ultimately pump
blood through the rest of the body. Experiments in ZDF rats have shown that fat is
increasingly accumulated in the heart as a result of increased fat transport across the heart
cell membranes not due to reductions in mitochondrial number or function, indicating that
lipids accumulate in the heart despite normal mitochondrial content, long-chain fatty acid
(LCFA) oxidation and morphology (Holloway et al., 2011). Increased sarcolemma LCFA
transport proteins and rates of LCFA transport result in a greater number of lipid droplets
within cardiac muscle (Holloway et al., 2011).
Several studies have reported that metabolic changes in the heart of ZDF rats were
higher compared to healthy controls (Baynes & Murray, 2009; Raza et al., 2012).
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Increased ROS production and lipid peroxidation, increased cytochrome activity
(CYP4502E1), accompanied by increased protein expression, oxidative protein
carbonylation and increased expression of other oxidative stress marker proteins including
inhaled nitric oxide (iNO) and heme oxygenase-1 (HO-1). Similarly, glutathione (GSH)
concentration and activities of GSH-dependent enzymes, GSH reductase and glutathione
S-transferase were, also significantly increased in ZDF rat heart tissues suggestive of a
compensatory defense mechanism (Raza et al., 2012). The activities of complex I and IV
mitochondrial respiratory enzymes were significantly reduced in the ventricle of ZDF rats
compared to ZL rats. Other studies have suggested a reduction in the expression of IκB-α
and phosphorylated-JNK in diabetic heart tissue. It was also reported that mitochondrial
dysfunction and increased oxidative stress in ZDF rats could be associated, at least in part,
with changes in the signaling of redox cells dependent on NF-κB/JNK (Raza et al., 2012).
In another study, the contractility of ventricular myocytes was well maintained,
regardless of the altered Ca2+ transport mechanisms and a change in mRNA pattern in the
older ZDF heart. The expression of genes that encode heart muscle proteins, cell
membrane ion transport, membrane Ca2+ channels and intracellular Ca2+ transport proteins
were altered in various ways. Atp2a1, Cacna1g, Cacna1h, and Myl2 were upregulated
meanwhile Atp2a2, Cacna2d3, Tnnt2, Slc9a1, and Myh6 were downregulated in ZDF
ventricle compared to ZL controls. Moreover, well-preserved shortening of ventricular
myocytes was associated with a modified pattern of genes that encode different Ca2+
signals and cardiac muscle proteins in old ZDF rats (F. C. Howarth, 2012; F. C. Howarth
et al., 2011).
Another study found increased mechanical rigidity, modified extracellular matrix,
and pro-fibrotic gene expression profiles in the aorta of the insulin-resistant ZF/Fa rat.
Mechanical experiments of the ZF fa/fa aorta showed increased vascular rigidity in
longitudinal and circumferential directions compared to the ZL controls. The results also
showed unequal elevations in developed strain, which favored the longitudinal direction,
resulting in a loss of anisotropy. In ZF fa/fa aorta, an increase in the expression of
ﬁbronectin and collagen IV3 has been reported. Similarly, the expression of mRNA of the
transforming growth factor and numerous Smad proteins were increased in vessels of
insulin-resistant animals implicating a role for hyperinsulinemia in vascular stiffness.
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These data provide structural, mechanical, and molecular evidence for arteriosclerosis in
the ZF rat, all of which are hallmarks of DCM (Sista et al., 2005).
Previous studies have shown that T2DM, which is related to the progression of
CVD in female and male ZDF rats, is mechanistically and structurally different (LumNaihe et al., 2017). Male rats show heart fibrosis and significant inhibition of intracardiac
antifibrotic and anti-inflammatory cytokines. On the other hand, the heart of female rats is
protected against the loss of antifibrotic cytokines and does not develop fibrosis. However,
they still exhibit hypertrophy of the heart and cardiomyocyte, as shown by an increase in
the phosphorylation of Ser2448 residues of mTOR. Moreover, a reduction in capillary
density was common in male and female rats. It is possible that capillary rarefaction,
cardiac hypertrophy, and a female-specific loss of cardio-reparative angiotensin II receptor
2 (AGTR2) in the setting of a very high expression of pro-hypertrophic miR-208a (a
biomarker that promotes cardiac hypertrophy) could have contributed to increased
structural damage in myocardial cells in the form of loss and scarring of cardiomyocytes.
This study highlights the need for new heart assessments, such as non-invasive imaging in
diabetic women, to detect myocardial deformation, heart hypertrophy, and capillary
density (Lum-Naihe et al., 2017).

9.2 Hypothesis
• Expression of important cardiac muscle proteins and changes in muscle structure may
underlie defects in muscle contraction in ZDF and ZF rat.

9.3 Aims and objectives
• To explore the effects of obesity and diabesity on the expression of proteins and
structure of ventricular muscle in the ZDF and ZF compared to ZL rats.
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9.4 Methods
9.4.1 Protein assessment
Commonly referred to as “protein immunoblot” is the gold standard in identifying
and separating a specific protein in a pool of extracts from tissue lysate. The protein is
extracted based on molecular weight through gel electrophoresis, which is then transferred
to protein binding membrane (i.e. polyvinylidene fluoride (PVDF)), this membrane is then
incubated with specific labeled antibodies (primary and secondary) that detect the protein
of interest which can later be viewed using a developed film by means of fluorescent
methods (Mahmood & Yang, 2012; Meftahi et al., 2021). Following protein extraction,
the protein concentration in the extracts is measured and quantified by Bradford’s assay
which utilizes a spectrophotometer that measures the mass of the protein being loaded into
each well and to compare them on equivalent bases (Kielkopf et al., 2020). This step is
followed by electrophoresis by a porous acrylamide gel matrix, which separates proteins
with excellent resolution based on molecular mass. Gel electrophoresis utilizes the use of
sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE) that denature the component
proteins with an anionic detergent which binds them. This causes all the proteins to have
a negative charge which is proportional to their molecular mass. The proteins then move
across the pores of the matrix towards the positive electrode when voltage is applied
(Mahmood & Yang, 2012; Nowakowski et al., 2014). A diagram showing the workflow
is seen in Figure 53.

Figure 53: Western blot workflow. Adapted from (Meftahi et al., 2021).
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Heart left ventricles were obtained from the rats after sacrifice. Then, tissue samples
were snap-frozen in liquid nitrogen and stored in the freezer at -80°C for later use. After
thawing,

tissue

extracts

were

prepared

by

homogenization

on

ice

with

radioimmunoprecipitation (RIPA) lysis buffer (1× phosphate-buffered saline (PBS), 50
mM NaF, 0.5% Na deoxycholate (w/v), 0.1% sodium dodecyl sulfate (SDS), 1%
octylphenoxypolyethoxyethanol

(IGEPAL),

1.5

mM

Na3VO4,

1mM

phenylmethylsulfonyl fluoride (PMSF) and 1× Halt) protease/phosphatase inhibitor
cocktail, followed by centrifuging for 10 minutes at 3000-4000 RPM at 4ºC. The
supernatant was collected and quantitated with Bradford’s assay using BSA (10 mg/ml
stock) as standard. Western blot analysis was performed with 20-50 µg of nuclear,
cytoplasmic, or total cellular protein extracts which was loaded in 4-12% Tris-HCl SDSPAGE gels (Bio-Rad) using MOPS running buffer which contains (Tris, Mops Sah, SDS,
EDTA) and was transferred using a transfer buffer (Trizma Base, Glycine) onto a PVDF
membrane. Blocking was performed for 2 hours at room temperature with 5% non-fat
skimmed milk powder dissolved in TBST containing (Tween 20, NaCl, Trizma Base) for
1-3 hours. Extracts were then incubated with primary and secondary antibodies. The
following primary antibodies were used: glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (ab8245, Abcam), Myosin (ab50967, Abcam), Ryanodine (ab2868, Abcam),
SERCA2 (MA3-919, ThermoFisher Scientific), Tm (ab7785, Abcam), TnC (ab137130,
Abcam), TnI (ab47003, Abcam), TnT (ab8295, Abcam), Connexin (Cx45) (ab135474,
Abcam). The following secondary antibodies were used: Anti-rabbit IgG HRP-linked
antibody (7074S, Cell Signaling Technology) and Anti-mouse IgG HRP-linked antibody
(7076S, Cell Signaling Technology). The loading marker used was Kaleidoscope
(#1610375, Bio-Rad). Stripping of the membrane was done with a stripping buffer which
contained (Tris, SDS) followed by β-Mercaptoethanol incubation in a water bath at 60ºC
for 30 min followed by washing with TBST, then blocking and re-probing. Gel images
were scanned, and the signal intensity was quantified using ImageJ software (NIH)
(Schneider et al., 2012).
9.4.2 Ultrastructural assessment
The transmission electron microscope (TEM) (Figure 54) is an extremely important
tool in microbiology. The main concept is that a beam of electrons accelerated though
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condenser lenses at high voltage with wavelengths shorter than visible light by a factor of
105, are transmitted into a very thin (up to 20 nm) section of sample. The thin sample must
be dry and capable of scattering electrons in a vacuum in order to pass through the sample
and hit a fluorescent screen below the microscope and produce a detailed image which can
be visualized, stored and analyzed. The image quality is limited by the biological samples
which require specific processing techniques such as fixation and the use of electronscattering heavy metal stains to produce adequate contrast for imaging. This allows the
investigation of molecular structures of biological samples at greater depth (Burghardt &
Droleskey, 2006; Malatesta, 2021; Pennycook et al., 2006).

Figure 54: Transmission electron microscope
TEM was performed according to previously described techniques (Fahim et al.,
2013). After sacrifice hearts were removed and left ventricle tissue samples were dissected
from the same morphological area, free from other accessory tissues, cut into small pieces
and washed with 0.1M phosphate buffer and then immersed in a modified McDowell and
Trump (1976) fixative for 3 hours at room temperature. After rinsing with phosphate
buffer, the tissues were postfixed with 1% osmium tetroxide for 1 hour. The tissue samples
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were later washed with distilled water, dehydrated in a series of graded ethanol and
propylene oxide and then infiltrated and embedded in Agar100 epoxy resin and
polymerized at 65ºC for 24 hours. Blocks were trimmed to semithin and then ultrathin
sections were cut with an ultramicrotome (Leica EM UC7 Ultracuts Vienna, Austria).
Semithin sections (1.5 µm thickness) were stained with 1% aqueous toluidine blue on glass
slides. Ultrathin sections (95 nm) with gold color were collected on 200 mesh copper grids
and then were compared with uranyl acetate followed by lead citrate. The grids were
examined and photographed with a TEM (Tecnai Biotwin Spirit G2, FEI company
Eindhoven, Netherlands). Typical EM images in ventricular muscle from 5 ZL, 3 ZF and
5 ZDF groups of Zucker rat were analyzed per field at 6000x and 11500x magnification.
Images were also analyzed and quantified using ImageJ software (NIH).

9.5 Statistics
Results were reported as the mean ± SEM of ‘n’ observations. Statistical
comparisons were done by IBM SPSS and Origin 9.0 (OriginLab, Northampton,
Massachusetts, USA) statistics software using either the paired samples t test, independent
samples t test or one-way ANOVA then by Bonferroni corrected t tests for multiple
comparisons, as appropriate. P values of 0.05 and less were considered statistically
significant.

9.6 Results
9.6.1 Protein assessment results
Typical examples of Western blot gels are shown in Figure 55A. The mean fold
changes in protein expression are shown in Figure 55B. GAPDH was used as the loading
control. Myosin expression was significantly lower (p<0.05) in ZDF (0.53±0.07)
compared to ZF (1.45±0.02) but not compared to ZL (1.06±0.2) ventricle tissue.
Ryanodine expression was modestly elevated in ZDF and ZF compared to ZL ventricle
tissue. SERCA2 expression was significantly lower in ZDF (1.01±0.1) and ZF (0.85±0.04)
compared to ZL (1.45±0.11) ventricle tissue. Tm expression was significantly higher in
the ZF (0.51±0.05) group compared to ZDF (0.09±0.02) and ZL (0.16±0.03) controls. TnC
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expression was significantly lower in ZDF (0.16±0.08) and in ZF (0.28±0.05) compared
to ZL (0.64±0.05) ventricle tissue. Expression of TnI was significantly reduced in ZDF
and ZF and TnT was reduced in ZDF compared to ZL ventricle tissue. Cx45 was reduced
in ZDF and ZF compared to ZL ventricle tissue.

(A)

(B)

Figure 55: Assessment of proteins in ventricular muscle. (A) Original Western blot gels
and (B) mean fold changes. Error bars represent mean ± SEM. GAPDH was used as the
loading control (n=3-6 hearts). P values of 0.05 and less were considered statistically
significant.
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9.6.2 Ultrastructural assessment results
Morphometric analysis is shown in (Figure 56). Typical TEM images in ventricular
muscle from a ZL rat at 6000x magnification are shown in Figure 56A, and 11,500x
magnification in Figure 56B. Typical TEM images in ventricular muscle from a ZF rat at
6000x magnification are shown in Figure 56C, and 11,500x magnification in Figure 56D.
Typical TEM images in ventricular muscle from a ZDF rat at 6000x magnification are
shown in Figure 56E, and 11,500x magnification in Figure 56F. Mean sarcomere length
is shown in Figure 56G and mean mitochondria count in Figure 56H. Sarcomere length
was significantly (p<0.05) shorter in ZF (1.21±0.02 µm) compared to ZDF (1.61±0.03
µm) and ZL (1.71±0.01 µm) myocytes (Figure 56G). Mitochondria count was
significantly (p<0.05) lower in ZF (68.23±7.26) compared to ZDF (100.81±10.50) and ZL
(122.15±4.45) myocytes (Figure 56H).
Image analysis showed that ZL sarcomeres are well oriented with structured dark bands
and intercalated disks that are clearly visible, and the mitochondria have normal shape. In
ZF heart the sarcomeres are disorganized, dislocated, widened with spaces in between,
mitochondria are clogged, deformed and small, lipid droplets are present. Furthermore,
ZDF heart sarcomeres are not as well organized as in ZL, but better than in ZF heart.
Spaces are present in ZDF heart but not as much as ZF, lipid droplets are present, and
mitochondria are damaged as well as deformed.
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(A)

(B)

Figure 56: Assessment of structure in ventricular muscle. ZL: Sarcomeres are well
oriented, structured the dark bands which are clearly visible, intercalated disks is
connected and long, mitochondria are normal shaped. (A) Typical transmission electron
microscope images from a ZL rat per field at 6000x magnification and (B) 11,500x
magnification.
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(C)

(D)

Figure 56: Assessment of structure in ventricular muscle. ZF: Sarcomeres are
disorganized, dislocated, widened with spaces in between, mitochondria are clogged,
deformed and small, lipid droplets are present. (C) Typical TEM images from a ZF rat per
field at 6000x magnification and (D) 11,500x magnification (Continued).
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(E)

(F)
Figure 56: Assessment of structure in ventricular muscle. ZDF: Sarcomeres are not as well
organized as in ZL but better oriented than ZF, spaces are present but not as much as ZF,
lipid droplets are present, mitochondria are damaged and deformed. (E) Typical TEM
images from a ZDF rat at 6000x magnification and (F) 11,500x magnification (Continued).
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(G)

(H)

Figure 56: Assessment of structure in ventricular muscle. (G) Mean Sarcomere length and
(H) mean mitochondria count. Data are means ± SEM. n=78 ZL, 33 ZF and 39 ZDF
sections for Sarcomere length and n=26 ZL, 13 ZF and 16 ZDF for mitochondrial count
all from 5 ZL, 3 ZF and 5 ZDF rats. P values of 0.05 and less were considered statistically
significant (Continued).
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9.7 Discussion
9.7.1 Protein assessment
Ventricular muscle protein was assessed with Western blot. Myosin expression was
modestly lower in ZDF compared to ZF ventricle tissue which is consistent with a previous
study (Dillmann, 1980). Myosin was significantly higher in ZF compared to ZL ventricular
tissue. Ryanodine expression was modestly increased in ZDF and ZF compared to ZL
ventricle tissue although both ZL and ZDF were significantly lower compared to GAPDH
which was similarly reported previously compared to β-actin (Bidasee, Nallani, Henry, et
al., 2003; Bidasee, Nallani, Yu, et al., 2003). SERCA2 expression was significantly lower
in ZDF and ZF compared to ZL ventricle tissue. Expression of SERCA protein has been
variously reported in different studies (Leopoldo et al., 2011; Lima-Leopoldo et al., 2008;
Relling et al., 2006). As previously mentioned SERCA2 is important for SR Ca2+ handling
and a reduction in SERCA protein maybe associated with a reduction in SERCA pump
activity and lower uptake of Ca2+ into SR. Tm expression was higher in ZF compared to
ZDF and ZL ventricle tissue. Tm has been previously linked to hypertrophic
cardiomyopathy (Bottinelli et al., 1998; Sequeira et al., 2013). In this experiment we found
evidence of structural defects in ZF rat heart that can be interpreted as signs of cardiac
hypertrophy. TnC, TnI and TnT are very important in Ca2+ signaling and ECC coupling
(Solaro & Rarick, 1998) and they also show the same trend with minor differences.
Expression of TnI was reduced in ZDF and ZF and TnT was reduced in ZDF compared to
ZL ventricle tissue. TnT was reduced in ZDF compared to ZL ventricle tissue. These
myofilament proteins have been reported to be linked to dilated cardiomyopathy (Mirza et
al., 2005) and diabetes is also associated with dilated cardiomyopathy (Sakakibara et al.,
2011). In this study however, low expression indicates that contraction and relaxation may
be effected possibly due to a lack of force or dilatation in the muscle which can be observed
in the TEM sections in the ZF and ZDF groups. Finally, gap junction protein Cx45 is
important for electrical signal conduction between cardiac myocytes (Teunissen &
Bierhuizen, 2004). In this experiment the expression of Cx45 was reduced in ZDF and ZF
compared to ZL ventricle tissue which may have implications for disturbances in heart
rhythm which has been reported in a previous study (Sultan et al., 2021). Surprisingly, it
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has been reported that mRNA expression levels for Gja7 (Cx45) was significantly
increased in SAN from diabetic heart compared to controls (F. C. Howarth et al., 2007).
9.7.2 Ultrastructural assessment
Morphometric analysis of the sections indicated that sarcomeres are longest in ZL,
intermediate in ZDF and shortest in ZF myocytes. Similarly, the mitochondrial count is
highest in ZL, intermediate in ZDF and lowest in ZF myocytes. The differences in
mitochondrial count may reflect differences in size or metabolic activity between the
groups. Our research demonstrates that morphological changes in mitochondria and signs
of injury in the ZDF are consistent with previous diabetic studies (Okruhlicova et al., 2005;
Sakakibara et al., 2011) which indicates that cardiomyopathy is a common feature of
obesity and diabetes. Additionally, reduced energy utilization is associated with diabetes
(Taegtmeyer et al., 2002) and reductions in mitochondria could be a sign of altered energy
utilization and might be attributed to a more sedentary lifestyle in ZF as well as ZDF rats
and their increased body weights. Furthermore, diabetes has been associated with HF and
metabolic abnormalities have been reported previously (Amaral & Okonko, 2015; From
et al., 2010). Also, mitochondrial ROS are a major source of chronic oxidative stress in
HF. They are also responsible for causing electrical instability that leads to SCD (Dey et
al., 2018). Transplantation of mitochondria is a valuable method of therapeutic cardioprotection in conjunction with other therapies (Masuzawa et al., 2013).

9.8 Conclusions
• Evidence of molecular and structural defects in the ZF and ZDF rat heart were present.
• Reductions in mitochondrial count may suggest disturbances in energy metabolism in
ZF and to a lesser extent in ZDF rat heart.
• Changed expression of Ca2+ transport and muscle proteins might partly underlie the
defects in electro-mechanical function observed in ZDF and ZF rat heart.
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Chapter 10: General discussion, conclusions, translational limitations
and future directions
In general, both obesity and diabetes contribute to the disturbances in cardiac
performance in the ZF and ZDF rat. In this study, we have found evidence of structural
and molecular changes in the hearts of the animals which leads to disturbances in heart
rhythm, defects in the uptake and release of SR Ca2+, energy utilization and defects in
molecular muscle proteins responsible for contraction and relaxation indicating poor
cardiac functioning which leads to electro-mechanical dysfunction and eventually SCD.
Mortality and morbidity following an AMI in patients with T2DM may be caused
by an increase in sensitivity to ischemia reperfusion damage or alteration in the activation
of endogenous cardiovascular protection pathways modified by T2DM or ischemic
preconditioning (IPC). Results from a previous study (Jensen et al., 2018) indicated that
IPC reduced infarct size in all groups regardless of the presence of T2DM and its duration.
Compared to prediabetic onset rats, myocardial glucose oxidation rates were reduced
during stabilization and early reperfusion at onset of T2DM, but these animals retained the
ability to increase oxidation rate in late reperfusion. However, late onset diabetic rats had
low glucose oxidation rates throughout reperfusion and stabilization. Irrespective of
intrinsic differences in sensitivity to ischemia reperfusion injury, the cardioprotective
effect of IPC was conserved in pre, early and late stage T2DM and coupled with
adaptations to myocardial glucose oxidation capacity (Jensen et al., 2018).
As mentioned earlier, CaMKIIδ plays an important role in cardiac contraction and
relaxation. Since it plays an important part in altering intracellular Ca2+ handling in
cardiomyocytes ultimately leading to reduced cardiac performance. It is important to
consider it as one of the mechanisms underlying electromechanical dysfunction in the ZDF
heart (Daniels et al., 2018). An example of such dysfunction is AF which is associated
with high morbidity and mortality. Both structural and electrical remodeling contribute to
AF. Recently (Onal et al., 2017), a role for CaMKII in the regulation of persistent “late”
Na+ current (INaL) has been identified. A computational approach was used to test the
hypothesis that increased CaMKII-activated INaL in atrial myocytes interrupts Ca2+
homeostasis, potentiating arrhythmogenic after-depolarizations. Dynamic CaMKII
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activity and regulation of multiple downstream targets [PLB, ICaL, and the RyR] were
entered to an existing well-validated computational model of the human atrial AP. Model
simulations showed that constitutive CaMKII-dependent phosphorylation of NaV1.5 and
the subsequent increase in INaL successfully upset intracellular atrial myocyte CaMKII
signaling and ion homeostasis. INaL stimulates intracellular Ca2+ overload via forward
mode NCX activity, which increases the RyR open probability above that observed for the
CaMKII-dependent phosphorylation of RyR alone. Increased INaL improved atrial myocyte
repolarization defects (afterdepolarizations and alternans) in the setting of acute βadrenergic stimulation. The model was created to help identify new mechanisms for
controlling atrial NaV1.5 regulation (Onal et al., 2017).
At 11 weeks of age, experiments in isolated perfused ZDF hearts demonstrated a
preserved endothelium-dependent dilatation of coronary microvasculature regardless of
depressed cardiac mechanical function, coronary flow and increased oxidative stress
(Mourmoura et al., 2013). Another study examined whether arteriolar vasoconstrictor
dysfunction of skeletal muscle occurs first or occurs simultaneously with the onset of
diabetes and hypertension. Male ZDF rats aged 7, 13, and 20 months were used to
represent pre-diabetic, short-term, and long-term diabetes (Laughlin et al., 2008).
Vasoconstrictor responses, passive mechanical properties of isolated skeletal muscle
arterioles along with conscious mean arterial pressure (MAP), fasted plasma insulin and
glucose were measured. The study concluded that changes in vascular function resulting
from T2DM at selected times differ in the progression of the disease. Also, in skeletal
muscle arteriole, increased vasoconstrictor responses to NE and endothelin-1 (ET-1) in
pre-diabetes are arbitrated by a decrement in the counterinfluence of the NOS (nitric oxide
synthase) signaling mechanism. The results of the study by Laughlin et al (Laughlin et al.,
2008) proposed that an early increase in ET-1 and adrenergic-mediated vasoconstriction
impact the synchronized emergence of diabetes and hypertension. Additionally, it also
suggests that interventions aimed at increasing nitric oxide (NO) bioavailability during the
pre-diabetic state can help to combat hypertension associated with the onset of T2DM
(Laughlin et al., 2008).
Cardiac NE overflow has also been investigated in ZDF rats. The results showed
that cardiac NE overflow is inhibited in failing hearts from ZDF rats which can result from

200

inhibition of functional changes in the presynaptic alpha 2-adrenoceptor and can
contribute to heart autonomic neuropathy (Burgdorf et al., 2006).
The relationship between cardiomyocyte rich perivascular tissues (PVT) and
coronary arteries has been investigated in ZDF in T2DM. Specifically, the vasoactive
effects of the PVT in the arteries of the ZDF rat were compared with other T2DM animal
models. Vasocontractile and vasorelaxant functions of coronary septal arteries with and
without PVT were studied with wire morphography. The experiments confirmed that the
anti-contractual influences of PVTs are weakened in the coronary arteries of ZDF rats, but
not affected in the arteries of STZ treated rats. Endothelial dysfunction was reported in the
coronary septal arteries, with and without PVT, of ZDF rats, but not treated with STZ.
Different signaling between cardiomyocyte-rich PVT and coronary arteries may
contribute to cardiovascular complications in T2DM (Bonde et al., 2017).
In T2DM, impaired endothelium-dependent relaxation is due to a lack of
endothelium derived hyperpolarization (EDH) that is controlled by a decrease in ion
channel function in ZDF compared to ZL rats. It is proposed that the compensatory effect
of NO and EDH-associated, endothelium-dependent relaxation is reduced in ZDF rats.
Specific blockade of IKCa with TRAM-34 reduced NO and EDH-type relaxation in
diabetic rats, indicating an elevated contribution of IKCa in diabetic small mesenteric artery
(SMA) relaxation. This result was associated with increased IKCa mRNA and protein
expression which suggests an important role for IKCa in diabetic SMA as a target for
innovative treatment strategies (Schach et al., 2014).
Decreased CV, which is determined by cardiac structure, internal electrical
resistance and excitability, is an independent risk factor for re-entry arrhythmias. The
internal electrical resistance can be viewed as two resistors in series: first, the resistance
of the cell cytoplasm, which is determined by the cellular composition, e.g. the number of
intracellular organelles and non-conducting material like lipid droplets and second, the
resistance at the cell-cell junctions (Kléber & Rudy, 2004). CV has been found to be
reduced in ZDF rats. The CV dysfunction can be explained in part by the increased
lateralization of Cx43. Moreover, lipotoxicity may play a role in the development of
conduction disturbances and arrhythmias in T2DM (Ploug et al., 2013).

201

A recent method to detect cardiac dysfunction in rat models of T1DM (STZ) and
T2DM (ZDF) has been investigated. It was found that contraction and active relaxation
deteriorated more in T1DM than in T2DM by comparing speckle-tracking
echocardiography (STE)-derived parameters to the indices of left ventricular pressure
volume (LVPV) analysis. Among diastolic STE parameters, peak strain rate values
isovolumic relaxation (SrIVR) was more decreased in T1DM, however, peak strain rate
values in early diastole (SrE) were more reduced in T2DM. In contrast, diastolic stiffness
was impaired in T2DM. Similarly, STE described more severe systolic dysfunction in
T1DM. Also, in T1DM, peak strain rate values in systole (SrS) correlated with
contractility, SrIVR with active relaxation, while in T2DM SrE was related to cardiac
stiffness, cardiomyocyte diameter and fibrosis. In summary, strain and strain rate
parameters can be both valuable and feasible physiological measures to describe the
dynamic changes in contractility, active relaxation and LV stiffness in animal models of
T1DM and T2DM (Benke et al., 2018). Figure 57 summarizes the time course of
pathological changes that are taking place in the ZDF rat heart and that may lead to SCD.

Figure 57: Pathological changes in the ZDF heart leading to sudden cardiac death.
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10.1 Conclusions
The underlying mechanisms reveal disturbances in heart rhythm in ZDF and ZF
rats are likely to be multifactorial. HR was reduced by ageing and by diabesity in the
absence of changes in body temperature and physical activity. Reductions in HRV linked
with altered sympathovagal drive could partially underlie the disturbed HR in the ZDF rat
even in the absence of ANS control in the isolated perfused heart.
AMP of shortening is generally well preserved in ZDF myocytes. Defects in the
uptake and release of SR Ca2+ might partly underlie the altered time course of the Ca2+
transient and shortening in ventricular myocytes from ZDF rat.
Our results also indicate that ISO was less effective at generating an increase in the
AMP of shortening in ZDF and ZF compared to ZL myocytes and that defects in Ca2+
signaling, and in particular SR Ca2+ transport, might partly underlie these abnormalities.
We have found evidence of molecular and structural defects in the ZF and ZDF
rat heart. Our evidence suggests that SR Ca2+ handling as well as energy utilization are
compromised in ZDF and ZF myocytes. Myocyte contraction and relaxation may also be
affected in the ZDF and ZF rat due to muscle protein structural defects which may lead
to heart rhythm disturbance and poor cardiac function.

10.2 Translational implications
DCM is a complex disease with many factors influencing the disease progression
and outcome. Our research demonstrates that ageing and prolonged exposure to diabetic
risk factors would lead to worsened scenarios. It is important to target and implement
strategies that will prevent disease progression such as exercise training and therapeutic
interventions. Potential therapeutic interventions involving Ca2+/ calmodulin-dependent
kinase II (CaMKII) inhibitors might help improve myocardial function during T2DM as
well as Leptin therapeutic interventions which might also prove effectiveness against
obesity and T2DM.
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10.3 Future directions
The results of this study provide a strong foundation on which to develop functional
and structural studies to further understand the effects of obesity and diabesity on heart
dysfunction in the Zucker rat. Future experiments might include electrophysiological
investigation of different ion channels such as Na+ and K+ that are participating in the
generation and propagation of electrical activity in the heart, as well as AP experiments in
isolated ventricular myocytes. Further experiments could also investigate the AP of SAN
and the electrophysiology of the atria. Experiments directed towards oxidative stress and
measuring oxidative stress markers could also be performed. Experiments looking into
fibrosis and the pathways leading to fibrosis might also be of interest. Imaging techniques
including CT, MRI and echocardiography could be used to further understand the
hemodynamic changes associated with obesity and diabesity.

10.4 Limitations
The in-vivo biotelemetry data presented in this study document the changes in
electrophysiological and other physiological parameters in ZDF, ZF compared to ZL
control rats 24 hours a day, 7 days a week from the age of 2 to 6 months. The mechanisms
that underlie the disturbances in heart rhythm are likely to be multifactorial. The results of
this study provide a firm basis on which to develop functional and structural studies to
further understand the effects of obesity and diabesity on heart rhythm.
The number of rats was limited by the availability of grant funding, and
experiments were conducted at a single time point. It would have been interesting to carry
out experiments at different time points to evaluate the progression of electro-mechanical
dysfunction in obesity and diabesity. Limitations include the time of start of the recording
of the in-vivo biotelemetry which was commenced at 75 days of age where the animals
were big enough for us to surgically implant the transmitters since the transmitters were
relatively large. It would have been interesting to investigate the changes happening before
that period.
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This dissertation describes the molecular basis of Diabetic Cardiomyopathy.
DCM is a complex disease with many factors influencing the disease progression
and outcome. Our research demonstrates that ageing and prolonged exposure to
diabetic risk factors would lead to worsened scenarios. It is important to target
and implement strategies that will prevent disease progression such as exercise
training and therapeutic interventions.
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